Document:

EX-10.1

 Exhibit 10.1 

SECURITIES PURCHASE AGREEMENT 

This Securities Purchase Agreement (this “Agreement”) is dated as of December 16, 2013 by and among Wheeler Real
Estate Investment Trust, Inc., a Maryland corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser,” and collectively, the
“Purchasers”). 
 RECITALS 

A. The Company has authorized a series of convertible notes of the Company, in the form attached hereto as Exhibit A (the
“Convertible Notes”), which Convertible Notes shall be convertible into the Company’s shares of the common stock, par value $0.01 per share (the “Common Stock”), in accordance with the terms of the Convertible
Notes (as converted, the “Conversion Shares”). 
 B. The Company has authorized a series of non-convertible
senior notes of the Company, in the form attached hereto as Exhibit B (the “Non-Convertible Notes” and, together with the Convertible Notes, the “Notes”). 

C. Each Purchaser wishes to purchase, and the Company wishes to sell, upon the terms and conditions stated in this Agreement,
(i) that aggregate principal amount of the Notes set forth below such Purchaser’s name on the signature page of this Agreement (which aggregate amount for all Purchasers shall be no greater than $12,000,000); and (ii) warrants, in
substantially the form attached hereto as Exhibit C (the “Warrants”), to acquire up to that number of additional shares of Common Stock set forth below such Purchaser’s name on the signature page of this Agreement (as
exercised, collectively, the “Warrant Shares” and together with the Conversion Shares, the “Underlying Shares”). The Notes, Conversion Shares, Warrants and Warrant Shares collectively are referred to herein as the
“Securities.” 
 D. The Company has engaged Maxim Group, LLC (“Maxim”), to act as placement agent
for the sale of the Securities (the “Offering”) on a “best efforts” basis. 
 E. The Company and
each Purchaser are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded by Section 4(2) of the Securities Act of 1933, as amended (the “Securities Act”), and Rule 506
of Regulation D (“Regulation D”) as promulgated by the United States Securities and Exchange Commission (the “Commission”) under the Securities Act. 

F. Contemporaneously with the execution and delivery of this Agreement, the parties hereto are executing and delivering a Registration
Rights Agreement, substantially in the form attached hereto as Exhibit D (the “Registration Rights Agreement”), pursuant to which, among other things, the Company will agree to provide certain registration rights with
respect to the Underlying Shares under the Securities Act and the rules and regulations promulgated thereunder and applicable state securities laws. 

 NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and
for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and the Purchasers hereby agree as follows: 

ARTICLE I 

DEFINITIONS 
 1.1
Definitions. In addition to the terms defined elsewhere in this Agreement, for all purposes of this Agreement, the following terms shall have the meanings indicated in this Section 1.1: 

“Action” means any action, suit, notice of violation, proceeding (including any partial proceeding such as a
deposition) or investigation pending or, to the Company’s Knowledge, overtly threatened against the Company, any Subsidiary or any of their respective properties or any officer, director or employee of the Company or any Subsidiary acting in
his or her capacity as an officer, director or employee, before or by any federal, state, county, local or foreign court, arbitrator, governmental or administrative agency, regulatory authority, stock market, stock exchange or trading facility.

 “Affiliate” means, with respect to any Person, any other Person that, directly or indirectly through one or
more intermediaries, Controls, is controlled by or is under common control with such Person, as such terms are used in and construed under Rule 405 under the Securities Act. 

“Agreement” has the meaning set forth in the Preamble. 

“Board of Directors” means the board of directors of the Company. 

“Business Day” means any day except Saturday, Sunday, any day which is a federal legal holiday in the United States or any
day on which banking institutions in the Commonwealth of Virginia are authorized or required by law or other governmental action to close. 

“Closing” means the closing of the purchase and sale of the Notes and Warrants pursuant to this Agreement. 

“Closing Bid Price” has the meaning set forth in Section 4.1(f). 

“Closing Date” means the Trading Day when all of the Transaction Documents have been executed and delivered by the applicable
parties thereto, and all of the conditions set forth in Sections 2.1, 2.2, 5.1 and 5.2 hereof are satisfied or waived, as the case may be, or such other date as the parties may agree. 

“Code” means the Internal Revenue Code of 1986, as amended. 

“Commission” has the meaning set forth in the Recitals. 

“Common Stock” has the meaning set forth in the Recitals. 

“Company” has the meaning set forth in the Preamble. 

 “Company Counsel” means Kaufman & Canoles, P.C., or such other legal
counsel as may be engaged by the Company. 
 “Company Deliverables” has the meaning set forth in
Section 2.2(a). 
 “Company’s Knowledge” means with respect to any statement made to the Company’s
Knowledge, that the statement is based upon the actual knowledge of the Company’s Chairman and Chief Executive Officer, Chief Financial Officer, or Secretary. 

“Control” (including the terms “controlling,” “controlled by” or “under common control with”)
means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise. 

“Convertible Notes” has the meaning set forth in the Recitals. 

“Conversion Shares” has the meaning set forth in the Recitals. 

“Current Value” means (i) in the case for which a public market exists for the Common Stock, a price per share equal to
(A) the average of the means between the closing bid and asked prices of the shares in the over-the-counter market for the prior 10 consecutive trading days, (B) if the Common Stock is quoted on the Nasdaq Capital Market, the average of
the means of the daily closing bid and asked prices of the shares for the prior 10 consecutive trading days, or (C) if the Common Stock is listed on any other national securities exchange, the average of the daily closing prices of the shares
for the prior 10 consecutive trading days, and (ii) in the case no public market exits at the time, the value determined by the Company’s Board of Directors in good faith. 

“Deadline Date” has the meaning set forth in Section 4.1(f). 

“Disclosure Materials” has the meaning set forth in Section 3.1(h). 

“Disclosure Schedules” has the meaning set forth in Section 3.1. 

“DTC” means The Depository Trust Company. 

“Effective Date” means the date on which the initial Registration Statement required by Section 2(a) of the Registration
Rights Agreement is first declared effective by the Commission. 
 “Effectiveness Deadline” means the date on which the
initial Registration Statement is required to be declared effective by the Commission under the terms of the Registration Rights Agreement. 

“Environmental Law” has the meaning set forth in Section 3.1(ee). 

“Evaluation Date” has the meaning set forth in Section 3.1(u). 

 “Exchange Act” means the Securities Exchange Act of 1934, as amended, or
any successor statute, and the rules and regulations promulgated thereunder. 
 “Final Closing Date” means
the date of the last closing of the purchase and sale of the Notes and the Warrants in the Offering. In the event an additional closing of the purchase and sale of the Notes and the Warrants in the Offering does not occur following the Closing Date,
the Closing Date shall also be the Final Closing Date. 
 “GAAP” means U.S. generally accepted accounting
principles, as applied by the Company. 
 “Hazardous Materials” has the meaning set forth in Section 3.1(ee).

 “Indemnified Person” has the meaning set forth in Section 4.7(b). 

“Intellectual Property Rights” has the meaning set forth in Section 3.1(q). 

“Lien” means any lien, charge, claim, encumbrance, security interest, right of first refusal, preemptive right or
other restriction of any kind. 
 “Material Adverse Effect” means a material adverse effect on the
operations, assets, business or condition (financial or otherwise) of the Company and its Subsidiaries, taken as a whole, except that any of the following, either alone or in combination, shall not be deemed a Material Adverse Effect:
(i) effects caused by changes or circumstances affecting general market or other conditions in the U.S. economy or which are generally applicable to the industry in which the Company operates, provided that such effects are not borne to a
materially disproportionate degree by the Company compared to other companies operating in the same industry as the Company; (ii) effects resulting from or relating to the announcement or disclosure of the sale of the Securities or other
transactions contemplated by this Agreement or the Offering; or (iii) effects caused by any event, occurrence or condition resulting from or relating to the taking of any action in accordance with this Agreement. 

“Material Contract” means any contract of the Company that has been filed or was required to have been filed as an
exhibit to the SEC Reports pursuant to Item 601(b)(4) or Item 601(b)(10) of Regulation S-K. 

“Maxim” has the meaning set forth in the Recitals. 

“New York Courts” means the state and federal courts sitting in the State of New York. 

“Non-Convertible Notes” has the meaning set forth in the Recitals. 

“Notes” has the meaning set forth in the Recitals. 

“Offering” has the meaning set forth in the Recitals. 

“Offering Termination Date” means the termination date of the Offering, which date shall be no later than
January 31, 2014. 

 “Person” means an individual, corporation, partnership, limited liability
company, trust, business trust, association, joint stock company, joint venture, sole proprietorship, unincorporated organization, governmental authority or any other form of entity not specifically listed herein. 

“Pink Sheets” has the meaning set forth in Section 4.1(f). 

“Press Release” has the meaning set forth in Section 4.4. 

“Principal Market” has the meaning set forth in Section 4.1(f). 

“Principal Trading Market” means the Trading Market on which the Common Stock is primarily listed on and/or quoted for
trading, which, as of the date of this Agreement and each Closing Date, shall be the NASDAQ Capital Market. 
 “Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding, such as a deposition), whether commenced or overtly threatened. 

“Purchaser” or “Purchasers” has the meaning set forth in the Preamble. 

“Purchaser Deliverables” has the meaning set forth in Section 2.2(b). 

“Purchaser Party” has the meaning set forth in Section 4.7(a). 

“Registration Rights Agreement” has the meaning set forth in the Recitals. 

“Registration Statement” means a registration statement meeting the requirements set forth in the Registration Rights
Agreement and covering the resale by the Purchasers of the Registrable Securities (as defined in the Registration Rights Agreement). 

“Regulation D” has the meaning set forth in the Recitals. 

“REIT” has the meaning set forth in Section 3.1(dd). 

“Required Approvals” has the meaning set forth in Section 3.1(e). 

“Required Delivery Date” has the meaning set forth in Section 4.1(d). 

“Required Purchasers” means the holders of at least 66.66% of the aggregate number of Registrable Securities issued and
issuable hereunder and under the Notes and Warrants. 
 “Resolutions” has the meaning set forth in
Section 4.12. 
 “Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act,
as such Rule may be amended from time to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. 

“SEC Reports” has the meaning set forth in Section 3.1(h). 

 “Securities” has the meaning set forth in the Recitals. 

“Securities Act” has the meaning set forth in the Recitals. 

“Seller” has the meaning set forth in Section 3.1(k). 

“Shareholder Approval” has the meaning set forth in Section 4.12. 

“Shareholder Approval Date” has the meaning set forth in Section 4.12. 

“Shareholder Matter” has the meaning set forth in Section 4.12. 

“Shareholder Meeting” has the meaning set forth in Section 4.12. 

“Short Sales” include, without limitation (i) all “short sales” as defined in Rule 200 promulgated under
Regulation SHO under the Exchange Act, whether or not against the box, and all types of direct and indirect stock pledges, forward sale contracts, options, puts, calls, short sales, swaps, “put equivalent positions” (as defined in
Rule 16a-1(h) under the Exchange Act) and similar arrangements (including on a total return basis), and (ii) sales and other transactions through non-U.S. broker dealers or foreign regulated brokers (but shall not be deemed to include the
location and/or reservation of borrowable shares of Common Stock). 
 “Subscription Amount” means, with respect to each
Purchaser, the aggregate amount to be paid for the Notes and Warrants purchased hereunder as indicated on such Purchaser’s signature page to this Agreement next to the heading “Aggregate Purchase Price (Subscription Amount)” in United
States dollars and in immediately available funds. 
 “Subsequent Offering” has the meaning set forth in Section
4.11. 
 “Subsidiary” or “Subsidiaries” means any subsidiary of the Company as set forth on
Schedule 3.1(a), and shall, where applicable, include any subsidiary of the Company formed or acquired after the date hereof. 

“Trading Day” means (i) a day on which the Common Stock is listed or quoted on its Principal Trading Market, or
(ii) if the Common Stock is not listed or quoted on any Trading Market, a day on which the Common Stock is quoted in the over the counter market as reported in the OTC Pink (also known as “Pink Sheets”) by OTC Markets Group Inc. (or
any similar organization or agency succeeding to its functions of reporting prices); provided, that in the event that the Common Stock is not listed or quoted as set forth in clause (i) or (ii) above, then Trading Day shall mean a
Business Day. 
 “Trading Market” means whichever of the New York Stock Exchange, the NYSE MKT, the NASDAQ Stock Market
(any market tier) or the OTC Bulletin Board, on which the Common Stock is listed or quoted for trading on the date in question. 

“Transaction Documents” means this Agreement, the schedules and exhibits attached hereto, the Registration Rights Agreement
and any other documents or agreements explicitly contemplated hereunder. 

 “Transfer Agent” means Computershare Trust Company, N.A., the current
transfer agent of the Company, or any successor transfer agent for the Company.  
 “Underlying Shares” has the
meaning set forth in the Recitals. 
 “Warrants” has the meaning set forth in the Recitals. 

“Warrant Shares” has the meaning set forth in the Recitals. 

ARTICLE II 
 PURCHASE
AND SALE 
 2.1 Closing. 

(a) Amount. Subject to the terms and conditions set forth in this Agreement, at the Closing, the Company shall issue and sell to each
Purchaser, and each Purchaser shall, severally and not jointly, purchase from the Company, (i) the principal amount of Convertible Notes as is set forth above such Purchaser’s name on the signature page of this Agreement, (ii) the
principal amount of Non-Convertible Notes as is set forth above such Purchaser’s name on the signature page of this Agreement, and (iii) the Warrants to acquire up to that number of Warrant Shares as is set forth above such
Purchaser’s name on the signature page of this Agreement. 
 (b) Closing. The Closing of the purchase and sale of the Securities
pursuant to this Agreement shall take place at the offices of Kaufman & Canoles, P.C., on the Closing Date or at such other location or remotely by facsimile transmission or other electronic means as determined by the Company. 

(c) Form of Payment. Unless otherwise agreed by the Company, on or before the Closing Date, each Purchaser shall wire its Subscription
Amount, in United States dollars and in immediately available funds, to a trust account in accordance with the written wire transfer instructions provided by Maxim. The Company shall deliver to each Purchaser the Convertible Notes and
Non-Convertible Notes (allocated in the principal amounts as such Purchaser shall request) which such Purchaser is then purchasing hereunder along with the Warrants (allocated in the amounts as such Purchaser shall request) which such Purchaser is
purchasing, in each case duly executed on behalf of the Company and registered in the name of such Purchaser or its designee. 
 (d) The
Purchasers and the Company agree that the Non-Convertible Notes and the Warrants constitute an “investment unit” for purposes of Section 1273(c)(2) of the Code. On or prior to the Closing Date, the Purchasers may notify the Company of
their determination of the allocation of the issue price of such investment unit between the Non-Convertible Notes and the Warrants in accordance with Section 1273(c)(2) of the Code and Treasury Regulation Section 1.1273-2(h), and neither
the Purchasers nor the Company shall take any position inconsistent with such allocation in any tax return or in any judicial or administrative proceeding in respect of taxes. 

 (e) Unless the Company obtains prior shareholder approval for such excess issuance, in no event
shall the number of Underlying Shares exceed 19.9% of the number of the Company’s issued and outstanding shares of Common Stock on the date of this Agreement. As such, the maximum number of Underlying Shares shall be 1,417,079 which number
shall be increased upon receipt of Shareholder Approval, if any. 
 2.2 Closing Deliveries. 

(a) At or prior to the Closing, the Company shall issue, deliver or cause to be delivered to each of the Purchasers, the following (the
“Company Deliverables”): 
 (i) this Agreement, duly executed by the Company; 

(ii) the Convertible Notes and Non-Convertible Notes (allocated in such principal amounts as such Purchaser shall request), being purchased
by such Purchaser at the Closing pursuant to this Agreement; 
 (iii) the Warrants (allocated in such amounts as such Purchaser shall
request) being purchased by such Purchaser at the Closing pursuant to this Agreement; 
 (iv) a legal opinion from Company Counsel, in form
reasonably satisfactory to the Purchasers, dated as of the Closing Date, executed by such counsel and addressed to the Purchasers and Maxim; 

(v) the Registration Rights Agreement, duly executed by the Company; 

(vi) a certificate of the Chief Executive Officer and the Chief Financial Officer of the Company, dated as of the Closing Date, certifying to
the capitalization of the Company and the matters in Section 5.1 hereof; and 
 (vii) a certificate of the Secretary of the Company,
dated as of the Closing Date, (a) certifying the resolutions adopted by the Board of Directors of the Company or a duly authorized committee thereof approving the transactions contemplated by this Agreement and the other Transaction Documents
and the issuance of the Securities, and (b) certifying the current versions of the charter and bylaws of the Company. 
 (b) At or
prior to the Closing, each Purchaser shall deliver or cause to be delivered to the Company the following (the “Purchaser Deliverables”): 

(i) this Agreement, duly executed by such Purchaser; 

(ii) its Subscription Amount; 

(iii) the Registration Rights Agreement, duly executed by such Purchaser; and 

 (iv) a fully completed and duly executed Accredited Investor Questionnaire and Stock
Registration Questionnaire in the forms attached hereto as Exhibits E and F, respectively. 
 ARTICLE III 

REPRESENTATIONS AND WARRANTIES 

3.1 Representations and Warranties of the Company. Except as set forth in the schedules delivered herewith (the “Disclosure
Schedules”), which Disclosure Schedules shall be deemed a part hereof and shall qualify any representation made herein to the extent of the disclosure contained in the corresponding section of the Disclosure Schedules or other
representation relating to the subject matter of such disclosure, the Company hereby represents and warrants as of the date hereof and as of the Closing Date (except for the representations and warranties that speak as of a specific date, which
shall be made as of such date), to each Purchaser: 
 (a) Subsidiaries. The Company has no direct or indirect Subsidiaries other than
those listed in Schedule 3.1(a) hereto. Except as disclosed in Schedule 3.1(a) hereto, the Company owns, directly or indirectly, all of the capital stock or comparable equity interests of each Subsidiary, if any, free and
clear of any and all Liens, and all the issued and outstanding shares of capital stock or comparable equity interest of each Subsidiary, if any, are validly issued and are fully paid, non-assessable and free of preemptive and similar rights to
subscribe for or purchase securities. 
 (b) Organization and Qualification. The Company and each of its Subsidiaries is an entity
duly incorporated or otherwise organized, validly existing and in good standing under the laws of the jurisdiction of its incorporation or organization (as applicable), with the requisite power and authority to own or lease and use its properties
and assets and to carry on its business as currently conducted. Neither the Company nor any Subsidiary is in violation or default of any of the provisions of its respective articles of incorporation, bylaws or other organizational or charter
documents. The Company and each of its Subsidiaries is duly qualified to conduct business and is in good standing as a foreign corporation or other entity in each jurisdiction in which the nature of the business conducted or property owned by it
makes such qualification necessary, except where the failure to be so qualified or in good standing, as the case may be, would not have a Material Adverse Effect, and no Proceeding has been instituted, is pending, or, to the Company’s
Knowledge, has been threatened in any such jurisdiction revoking, limiting or curtailing or seeking to revoke, limit or curtail such power and authority or qualification. 

(c) Authorization; Enforcement; Validity. The Company has the requisite corporate power and authority to enter into and to consummate
the transactions contemplated by each of the Transaction Documents to which it is a party and otherwise to carry out its obligations hereunder and thereunder. The Company’s execution and delivery of each of the Transaction Documents to which it
is a party and the consummation by it of the transactions contemplated hereby and thereby (including, but not limited to, the sale and delivery of the Securities in accordance with the terms hereof and the issuance of the Underlying Shares in
accordance herewith) have been duly authorized by all necessary corporate action on the part of the Company, and no further corporate action is required by the Company, its Board of Directors 

 
or its stockholders in connection therewith other than in connection with the Required Approvals. Each of the Transaction Documents to which the Company is a party has been (or upon delivery will
have been) duly executed by the Company and is, or when delivered in accordance with the terms hereof, will constitute the legal, valid and binding obligation of the Company enforceable against the Company in accordance with its terms, except
(i) as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and remedies or by other
equitable principles of general application, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and contribution provisions may
be limited by applicable law. 
 (d) No Conflicts. The execution, delivery and performance by the Company of the Transaction
Documents to which it is a party and the consummation by the Company of the transactions contemplated hereby or thereby (including, without limitation, the issuance of the Securities) do not and will not (i) conflict with or violate any
provisions of the Company’s charter or bylaws or otherwise result in a violation of the organizational documents of the Company, (ii) conflict with, or constitute a default (or an event that with notice or lapse of time or both would
result in a default) under, result in the creation of any Lien upon any of the properties or assets of the Company or give to others any rights of termination, amendment, acceleration or cancellation (with or without notice, lapse of time or both)
of, any Material Contract, or (iii) subject to the Required Approvals, conflict with or result in a violation of any law, rule, regulation, order, judgment, injunction, decree or other restriction of any court or governmental authority to which
the Company is subject (including federal and state securities laws, assuming the correctness of the representations and warranties made by the Purchasers herein), or by which any property or asset of the Company is bound or affected, except in the
case of clauses (ii) and (iii) such as would not, individually or in the aggregate, have a Material Adverse Effect. 
 (e)
Filings, Consents and Approvals. Neither the Company nor any of its Subsidiaries is required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration with, any court or other federal,
state, local or other governmental authority, self-regulatory organization (including the Principal Trading Market) or other Person in connection with the execution, delivery and performance by the Company of the Transaction Documents (including,
without limitation, the issuance of the Securities), other than (i) the filing with the Commission of one or more Registration Statements in accordance with the requirements of the Registration Rights Agreement, (ii) filings required by
applicable state securities laws, (iii) the filing of a Notice of Exempt Offering of Securities on Form D with the Commission under Regulation D of the Securities Act, (iv) the filing of any requisite notices and/or application(s) to
the Principal Trading Market for the issuance and sale of the Underlying Shares and the listing of the Underlying Shares for trading or quotation, as the case may be, thereon in the time and manner required thereby, (v) the filings contemplated
in Section 4.4 of this Agreement, (vi) Shareholder Approval required by Section 4.12 hereof; and (vii) those that have been made or obtained prior to the date of this Agreement (collectively, the “Required
Approvals”). 
 (f) Issuance of the Securities. The issuance of the Notes and the Warrants are duly authorized and are free
from all Liens with respect to the issue thereof. Upon conversion or 

 
exercise in accordance with the Notes or the Warrants in accordance with their terms, as the case may be, the Conversion Shares and the Warrant Shares, respectively, will be validly issued, fully
paid and nonassessable and free and clear of all Liens, other than restrictions on transfer provided for in the Transaction Documents or imposed by applicable securities laws, and shall not be subject to preemptive or similar rights of stockholders.
Assuming the accuracy of the representations and warranties of the Purchasers in this Agreement and the timely filing of the Required Approvals referenced in Section 3.1(e)(iv), the Securities will be issued in compliance with all
applicable federal and state securities laws. 
 (g) Capitalization. No Person has any right of first refusal, preemptive right,
right of participation, or any similar right to participate in the transactions contemplated by the Transaction Documents that have not been effectively waived as of the Closing Date. The issuance and sale of the Securities will not obligate the
Company to issue shares of Common Stock or other securities to any Person (other than the Purchasers) and will not result in a right of any holder of Company securities to adjust the exercise, conversion, exchange or reset price under any of such
securities. All of the outstanding shares of capital stock of the Company are validly issued, fully paid and nonassessable, have been issued in compliance with all applicable federal and state securities laws, and none of such outstanding shares was
issued in violation of any preemptive rights or similar rights to subscribe for or purchase securities. No further approval or authorization of any stockholder, the Board of Directors or others is required for the issuance and sale of the Securities
and the issuance of the Underlying Shares. 
 (h) SEC Reports; Disclosure Materials. The Company has filed with the Commission all
reports, schedules, forms, statements and other documents required to be filed by the Company under the Exchange Act, including pursuant to Section 13(a) or 15(d) thereof (the foregoing materials, including the exhibits thereto and documents
incorporated by reference therein, being collectively referred to herein as the “SEC Reports,” and the SEC Reports, together with the Disclosure Schedules, being collectively referred to as the “Disclosure
Materials”). As of their respective filing dates, or to the extent corrected or updated by a subsequent amendment or restatement, the SEC Reports complied in all material respects with the requirements of the Exchange Act and the rules and
regulations of the Commission promulgated thereunder, and none of the SEC Reports, when filed, contained any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make the
statements therein, in light of the circumstances under which they were made, not misleading. Each of the Material Contracts to which the Company or any Subsidiary is a party or to which the property or assets of the Company or any of its
Subsidiaries are subject has been filed (or incorporated by reference) as an exhibit to the SEC Reports. 
 (i) Financial Statements.
The financial statements of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules and regulations of the Commission with respect thereto as in effect at the time of filing (or
to the extent corrected or updated by a subsequent amendment or restatement). Such financial statements have been prepared in accordance with GAAP, except as may be otherwise specified in such financial statements or the notes thereto and except
that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material respects the financial position of the Company and its consolidated subsidiaries taken as a whole as of and for the dates thereof
and the results of operations and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal year-end audit adjustments. 

 (j) Material Changes. Since the date of the latest audited financial statements included
within the SEC Reports, except as disclosed in a subsequent SEC Report filed prior to the date hereof, (i) there have been no events, occurrences or developments that have had or would reasonably be expected to have, either individually or in
the aggregate, a Material Adverse Effect, (ii) the Company has not incurred any material liabilities (contingent or otherwise) other than (A) trade payables and accrued expenses incurred in the ordinary course of business consistent with
past practice and (B) liabilities not required to be reflected in the Company’s financial statements pursuant to GAAP or disclosed in filings made with the Commission, (iii) the Company has not altered materially its method of
accounting or the manner in which it keeps its accounting books and records, (iv) the Company has not declared or made any dividend or distribution of cash or other property to its stockholders or purchased, redeemed or made any agreements to
purchase or redeem any shares of its capital stock, and (v) there has not been any material change or amendment to, or any waiver of any material right by the Company under, any Material Contract under which the Company or any of its
Subsidiaries is bound or subject. 
 (k) Litigation. There is no Action which (i) adversely affects or challenges the legality,
validity or enforceability of any of the Transaction Documents or the issuance of the Securities or (ii) except as disclosed in the SEC Reports, would, if there were an unfavorable decision, individually or in the aggregate, have or reasonably
be expected to result in a Material Adverse Effect. There are no Actions pending or, to the Company’s Knowledge, threatened or contemplated to which the Company or any of its Subsidiaries or any of their respective directors or officers (or, to
the Company’s Knowledge, any Person from whom the Company or any of its Subsidiaries acquired any real property or any portion thereof owned or leased by the Company or any of its Subsidiaries (each, a “Seller”), or any tenant
or subtenant of any property or any portion thereof owned or leased by the Company or any of its Subsidiaries) is or would be a party or of which any of the respective properties or assets of the Company or any of its Subsidiaries, or any real
property owned or leased by the Company or any of its Subsidiaries, is or would be subject at law or in equity, before or by any federal, state, local or foreign governmental or regulatory commission, board, body, authority or agency, or before or
by any self-regulatory organization or other non-governmental regulatory authority, except any such action, suit, claim, investigation or proceeding which, if resolved adversely to the Company or any of its Subsidiaries, such seller or such tenant
or subtenant, would not, individually or in the aggregate, have a Material Adverse Effect. 
 (l) Compliance. Except as disclosed in
Schedule 3.1(l), neither the Company or any of its Subsidiaries (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the
Company or any of its Subsidiaries under), nor has the Company or any of its Subsidiaries received written notice of a claim that it is in default under or that it is in violation of, any Material Contract (whether or not such default or violation
has been waived), (ii) is in violation of any order of any court, arbitrator or governmental body having jurisdiction over the Company, its Subsidiaries or their respective properties or assets, or (iii) is in violation of, or in receipt
of written notice that it is in violation of, any statute, rule or regulation of any governmental authority or self-regulatory organization (including the Principal Trading Market) applicable to the Company, except in each case as would not,
individually or in the aggregate, have a Material Adverse Effect. 

 (m) Regulatory Permits. Each of the Company and its Subsidiaries has all necessary
licenses, permits, authorizations, consents and approvals, possesses valid and current certificates, has made all necessary filings required under any federal, state or local law, regulation or rule, and has obtained all necessary authorizations,
consents and approvals from other persons, required in order to conduct their respective businesses and own their respective properties and other assets, except to the extent that any failure to have any such licenses, permits, authorizations,
consents or approvals, to make any such filings or to obtain any such authorizations, consents or approvals, individually or in the aggregate, would not reasonably be expected to have a Material Adverse Effect. Neither the Company nor any of its
Subsidiaries is in violation of, or in default under, or has received any notice regarding a possible violation, default or revocation of any such license, permit, authorization, consent or approval, or any federal, state or local law, regulation or
rule or any decree, order or judgment applicable to the Company or any of its Subsidiaries, except where such violation, default or revocation would not, individually or in the aggregate, have a Material Adverse Effect. 

(n) Title to Assets. The Company and its Subsidiaries have good and marketable title in fee simple to all real properties owned by
them, in each case free and clear of all liens, claims, security interests, pledges, charges, encumbrances, encroachments, restrictions, mortgages, and other defects, except (i) such as are disclosed in the Disclosure Schedules,
(ii) indebtedness secured by real property reflected in the financial statements in the SEC Reports, (iii) such as are listed as an exception to any owner’s or leasehold title insurance policy with respect to such properties or
otherwise set forth in any loan or financing documentation relating to such properties, in each case made available by the Company to the Purchasers, (iv) for the leasehold interests of the tenants, or (iv) such as except would not,
individually or in the aggregate, have a Material Adverse Effect; any real property leased by the Company or any of its Subsidiaries is held under valid, existing, and enforceable leases, with such exceptions as are not material and do not interfere
with the use made or proposed to be made of such property by the Company and its Subsidiaries; the Company or its Subsidiaries have obtained an owner’s title insurance policy, from a title insurance company licensed to issue such policy, on
each property that is owned by the Company or such Subsidiary that insures the Company or such Subsidiary’s fee interest in such property, or a lender’s title insurance policy insuring the lien of its mortgage securing such property with
coverage equal to the maximum aggregate principal amount of any indebtedness held by the Company or such Subsidiary and secured by such property. Each of the leases pertaining to real property held under lease by the Company or a Subsidiary has been
duly authorized by the Company or such Subsidiary, as applicable, and is a valid, subsisting, and enforceable agreement of the Company or such Subsidiary, as applicable, and to the Company’s Knowledge, each other party thereto, enforceable in
accordance with its terms, except as such enforceability may be limited by bankruptcy, insolvency, reorganization, or other similar laws affecting creditor’s rights generally or general equitable principles. The Company and its Subsidiaries
have good and marketable title to all tangible personal property owned by them that is material to the business of the Company and its Subsidiaries, taken as whole, in each case free and clear of all Liens except as disclosed in the Disclosure
Schedules or such as do not materially affect the value of such property and do not interfere with the use made and proposed to be made of such property by the Company and any of its Subsidiaries. 

 (o) Real Property Compliance. Each of the real properties owned or leased by the Company
or its Subsidiaries complies with all applicable zoning laws, ordinances, regulations, and deed restrictions or other covenants in all material respects or, if and to the extent there is a failure to comply, such failure does not impair the value of
any of the properties and will not result in a forfeiture or reversion of title, except where such failure to comply would not, individually or in the aggregate, have a Material Adverse Effect; there is no pending or, to the Company’s
Knowledge, threatened condemnation, zoning change or other similar proceeding or action that will in any material respect affect the size or use of, improvements on, or construction on or access to the properties, except such zoning changes,
proceedings, or actions that individually or in the aggregate would not reasonably be expected to have a Material Adverse Effect; to the Company’s Knowledge, no tenant of any portion of any of the properties is in default under any of the
leases governing such properties and there is no event which, but for the passage of time or the giving of notice or both would constitute a default under any of such leases, or such defaults that would not reasonably be expected to have a Material
Adverse Effect. 
 (p) Mortgages and Deeds of Trust. The mortgages and deeds of trust encumbering the real property owned by the
Company and its Subsidiaries are not convertible into debt or equity securities of the Company, nor does the Company hold a participating interest therein, and such mortgages and deeds of trust are not cross-defaulted or cross-collateralized to any
property not owned directly or indirectly by the Company or its Subsidiaries. 
 (q) Patents and Trademarks. To the Company’s
Knowledge, the Company and its Subsidiaries own, possess, license or have other rights to use, all patents, patent applications, trade and service marks, trade and service mark applications and registrations, trade names, trade secrets, inventions,
copyrights, licenses, technology, know-how and other intellectual property rights and similar rights necessary or material for use in connection with their respective businesses as described in the SEC Reports and which the failure to so have would
have a Material Adverse Effect (collectively, the “Intellectual Property Rights”). There is no pending or, to the Company’s Knowledge, threatened action, suit, proceeding or claim by any Person that the Company’s business
as now conducted infringes or otherwise violates any patent, trademark, copyright, trade secret or other proprietary rights of such Person. To the Company’s Knowledge, there is no existing infringement by another Person of any of the
Intellectual Property Rights that would have a Material Adverse Effect. The Company and its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of all of their Intellectual Property Rights, except
where failure to do so would not, individually or in the aggregate, have a Material Adverse Effect. 
 (r) Insurance. The Company and
each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and risks and in such amounts as the Company believes to be prudent and customary in the businesses and locations in which the Company and
the Subsidiaries are engaged. Neither the Company nor any of its Subsidiaries has received any notice of cancellation of any such insurance, nor, to the Company’s Knowledge, will it or any Subsidiary be unable to renew their respective existing
insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business. 

 (s) Transactions With Affiliates and Employees. Except as set forth in the SEC Reports,
none of the executive officers or directors of the Company and, to the Company’s Knowledge, none of the employees of the Company is presently a party to any transaction with the Company or any Subsidiary (other than for services as employees,
officers and directors), that would be required to be disclosed pursuant to Item 404 of Regulation S-K promulgated under the Securities Act. 

(t) Internal Accounting Controls. The Company maintains a system of internal accounting controls sufficient to provide reasonable
assurance that (i) transactions are executed in accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to
maintain asset and liability accountability, (iii) access to assets or incurrence of liabilities is permitted only in accordance with management’s general or specific authorization, and (iv) the recorded accountability for assets and
liabilities is compared with the existing assets and liabilities at reasonable intervals and appropriate action is taken with respect to any differences. 

(u) Sarbanes-Oxley; Disclosure Controls. The Company is in compliance in all material respects with all of the provisions of the
Sarbanes-Oxley Act of 2002 which are applicable to it as of the Closing Date. The Company has established disclosure controls and procedures (as such term is defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) for the Company and
designed such disclosure controls and procedures to ensure that information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods
specified in the Commission’s rules and forms. The Company’s certifying officers have evaluated the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by the Company’s most
recently filed periodic report under the Exchange Act (such date, the “Evaluation Date”). The Company presented in its most recently filed periodic report under the Exchange Act the conclusions of the certifying officers about the
effectiveness of the disclosure controls and procedures based on their evaluations as of the Evaluation Date. Since the Evaluation Date, there have been no changes in the Company’s internal control over financial reporting (as such term is
defined in the Exchange Act) that has materially affected, or is reasonably likely to materially affect, the Company’s internal control over financial reporting. 

(v) Certain Fees. No person or entity will have, as a result of the transactions contemplated by this Agreement, any valid right,
interest or claim against or upon the Company or a Purchaser for any commission, fee or other compensation pursuant to any agreement, arrangement or understanding entered into by or on behalf of the Company, other than Maxim with respect to the
offer and sale of the Securities (which placement agent fees and expenses are being paid by the Company). The Company shall indemnify, pay, and hold each Purchaser harmless against, any liability, loss or expense (including, without limitation,
attorneys’ fees and out-of-pocket expenses) arising in connection with any such right, interest or claim. 
 (w) Private
Placement. Assuming the accuracy of the Purchasers’ representations and warranties set forth in Section 3.2 of this Agreement and the accuracy of the information disclosed in the Accredited Investor Questionnaires provided by
the Purchasers, no registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Purchasers under the Transaction Documents. Neither the issuance and sale of the Securities hereunder nor the
issuance of the Underlying Shares in accordance herewith will contravene the rules and regulations of the Principal Trading Market. 

 (x) Investment Company. The Company is not, and immediately after receipt of payment for
the Securities, will not be an “investment company” within the meaning of the Investment Company Act of 1940, as amended. The Company shall conduct its business in a manner so that it will not become subject to the Investment Company Act
of 1940, as amended. 
 (y) Listing and Maintenance Requirements. The Company’s Common Stock is registered pursuant to
Section 12(b) of the Exchange Act, and the Company has taken no action, and does not presently intend to take any action, designed to terminate the registration of the Common Stock under the Exchange Act, nor has the Company received any
notification that the Commission is contemplating terminating such registration. The Company has not, in the twelve (12) months preceding the date hereof, received written notice from the Principal Trading Market to the effect that the Company
is not in compliance with the listing or maintenance requirements of the Principal Trading Market. The Company is in material compliance with all listing and maintenance requirements of the Principal Trading Market on the date hereof. 

(z) Rights Agreements. The Company has not adopted any stockholder rights plan or similar arrangement relating to accumulations of
beneficial ownership of Common Stock or a change in control of the Company. 
 (aa) Disclosure. The Company confirms that it has not
provided, and to the Company’s Knowledge, none of its executive officers or directors nor any other Person acting on its or their behalf has provided, and it has not authorized Maxim to provide, any Purchaser or its respective agents or counsel
with any information that it believes constitutes material, non-public information except insofar as the existence, provisions and terms of the Transaction Documents and the proposed transactions hereunder may constitute such information, all of
which will be disclosed by the Company in the manner contemplated by Section 4.4 hereof. The Company understands and confirms that the Purchasers will rely on the foregoing representations in effecting transactions in securities of the
Company. 
 (bb) No Integrated Offering. Assuming the accuracy of the Purchasers’ representations and warranties set forth in
Section 3.2, neither the Company nor, to the Company’s Knowledge, any Person acting on its behalf has, directly or indirectly, at any time within the past six (6) months, made any offers or sales of any Company security or
solicited any offers to buy any Company security under circumstances that would (i) eliminate the availability of the exemption from registration under Regulation D under the Securities Act in connection with the offer and sale by the
Company of the Securities as contemplated hereby or (ii) cause the Offering to be integrated with prior offerings by the Company for purposes of any applicable law, regulation or stockholder approval provisions, including, without limitation,
under the rules and regulations of any Trading Market on which any of the securities of the Company are listed or quoted. 
 (cc) Tax
Matters. The Company and each of its Subsidiaries (i) has prepared and filed (or has requested valid extensions for) all foreign, federal and state income and all other tax returns, reports and declarations required by any jurisdiction to
which it is subject, and 

 
(ii) has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to be due on such returns, reports and declarations, except those
being contested in good faith, with respect to which adequate reserves have been set aside on the books of the Company, except in either case where the failure to prepare, file or pay would not have a Material Adverse Effect. There are no unpaid
taxes in any material amount claimed to be due by the Company or any of its Subsidiaries by the taxing authority of any jurisdiction. 

(dd) REIT Tax Status. The Company (i) has made a valid election under Section 856(c)(1) of the Code to be taxed as a
“real estate investment trust” (a “REIT”) effective as of its taxable year ending December 31, 2012, (ii) has been organized and has operated in conformity with the requirements for qualification and taxation as
a REIT under Sections 856 through 860 of the Code since January 1, 2012, to the date hereof and (iii) intends and expects to continue to be organized and to operate in conformity with the requirements for qualification and taxation as
a REIT under the Code. The operations of the Company and its Subsidiaries have enabled and will continue to enable the Company to meet the requirements for qualification and taxation as a REIT under the Code. 

(ee) Environmental Matters. The Company and its Subsidiaries and their respective properties and assets (and, to the Company’s
Knowledge, each tenant or subtenant of any real property or portion thereof owned or leased by the Company or its Subsidiaries) are in material compliance with, and each of the Company and its Subsidiaries hold all permits, authorizations and
approvals required under, Environmental Laws (as defined below), except to the extent that failure to so comply or to hold such permits, authorizations or approvals would not, individually or in the aggregate, have a Material Adverse Effect. Except
as would not, individually or in the aggregate, have a Material Adverse Effect, none of the Company or any of its Subsidiaries, nor, to the Company’s Knowledge, any seller, tenant or subtenant of any real property or portion thereof owned or
leased by the Company or any of its Subsidiaries or any previous owner thereof, (i) is the subject of any investigation, (ii) has received any notice or claim, (iii) is a party to or affected by any pending or, to the Company’s
Knowledge, threatened action, suit or proceeding, (iv) is bound by any judgment, decree or order or (v) has entered into any agreement, in each case relating to any alleged violation of any Environmental Law or any actual or alleged
release or threatened release or cleanup at any location of any Hazardous Materials (as defined below); and none of the Company or any of its Subsidiaries, nor, to the Company’s Knowledge, any seller, tenant or subtenant of any real property or
portion thereof owned or leased by the Company or any of its Subsidiaries or any previous owner thereof, has received from any governmental authority notice of any violation, concerning such properties, of any municipal, state or federal law, rule
or regulation or of any Environmental Law, except for such violations as have heretofore been cured and except for such violations as would not, individually or in the aggregate, have a Material Adverse Effect (as used herein, “Environmental
Law” means any federal, state or local law, statute, ordinance, rule, regulation, order, decree, judgment, injunction, permit, license, authorization or other binding requirement, or common law, relating to health, safety or the protection,
cleanup or restoration of the environment or natural resources, including those relating to the distribution, processing, generation, treatment, storage, disposal, transportation, other handling or release or threatened release of Hazardous
Materials, and “Hazardous Materials” means any material (including, without limitation, pollutants, contaminants, hazardous or toxic substances or wastes) that is regulated by or may give rise to liability under any Environmental
Law). 

 (ff) Environmental Law Costs and Liabilities. There are no costs or liabilities associated
with Environmental Laws (including, without limitation, any capital or operating expenditures required for clean-up, closure of properties or compliance with Environmental Laws or any permit, license or approval, any related constraints on operating
activities and any potential liabilities to third parties) which would, singly or in the aggregate, have a Material Adverse Effect on the Company and its Subsidiaries, taken as a whole. 

(gg) No General Solicitation. Neither the Company nor, to the Company’s Knowledge, any Person acting on behalf of the Company has
offered or sold any of the Securities by any form of general solicitation or general advertising (within the meaning of Regulation D). 

(hh) Off Balance Sheet Arrangements. There is no transaction, arrangement, or other relationship between the Company (or any
Subsidiary) and an unconsolidated or other off balance sheet entity that is required to be disclosed by the Company in its SEC Reports and is not so disclosed and would have a Material Adverse Effect. 

(ii) Acknowledgment Regarding Purchasers’ Purchase of Securities. The Company acknowledges and agrees that each of the Purchasers
is acting solely in the capacity of an arm’s length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby. The Company further acknowledges that no Purchaser is acting as a financial advisor or
fiduciary of the Company (or in any similar capacity) with respect to the Transaction Documents and the transactions contemplated thereby and any advice given by any Purchaser or any of their respective representatives or agents in connection with
the Transaction Documents and the transactions contemplated thereby is merely incidental to the Purchasers’ purchase of the Securities. The Company represents to each Purchaser that the Company’s decision to enter into this Agreement and
the other Transaction Documents has been based solely on the independent evaluation of the transactions contemplated hereby by the Company and its representatives. 

(jj) PFIC. Neither the Company nor any of its Subsidiaries is or intends to become a “passive foreign investment company”
within the meaning of Section 1297 of the U.S. Internal Revenue Code of 1986, as amended. 
 (kk) Reservation of Underlying
Shares. The Company has duly authorized and reserved, and will continue to reserve, free of any preemptive or similar rights of stockholders of the Company, a number of unissued shares of Common Stock, sufficient to issue and deliver the
Underlying Shares into which the Notes are convertible or the Warrants are exercisable, as the case may be. 
 3.2 Representations and
Warranties of the Purchasers. Each Purchaser hereby, for itself and for no other Purchaser, represents and warrants as of the date hereof and as of the Closing Date to the Company as follows: 

(a) Authority. The Purchaser is either an individual or an entity duly organized, validly existing and in good standing under the laws
of the jurisdiction of its organization with the requisite power and authority to enter into and to consummate the 

 
transactions contemplated by the applicable Transaction Documents and otherwise to carry out its obligations hereunder and thereunder. If the Purchaser is not an individual, the execution and
delivery of this Agreement by such Purchaser and performance by such Purchaser of the transactions contemplated by this Agreement have been duly authorized by all necessary action on the part of such Purchaser. Each Transaction Document to which the
Purchaser is a party has been duly executed by such Purchaser, and when delivered by such Purchaser in accordance with the terms hereof, will constitute the valid and legally binding obligation of such Purchaser, enforceable against it in accordance
with its terms, except (i) as such enforceability may be limited by applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally the enforcement of, creditors’ rights and
remedies or by other equitable principles of general application, (ii) as limited by laws relating to the availability of specific performance, injunctive relief or other equitable remedies and (iii) insofar as indemnification and
contribution provisions may be limited by applicable law. 
 (b) No Conflicts. The execution, delivery and performance by the
Purchaser of this Agreement and the other Transaction Documents to which it is a party, and the consummation by such Purchaser of the transactions contemplated hereby and thereby, will not (i) if applicable, result in a violation of the
organizational documents of such Purchaser, (ii) conflict with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, indenture or instrument to which such Purchaser is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws) applicable to
such Purchaser, except in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights or violations which would not, individually or in the aggregate, have a material adverse effect on the ability of such Purchaser to
perform its obligations hereunder or any of the other Transaction Documents to which such Purchaser is a party. 
 (c) Investment
Intent. The Purchaser understands that the Securities are “restricted securities” and have not been registered under the Securities Act or any applicable state securities law, and the Purchaser is acquiring the Securities as principal
for its own account and not with a view to, or for distributing or reselling such Securities or any part thereof in violation of the Securities Act or any applicable state securities laws; provided, however, that by making the
representations herein, such Purchaser does not agree to hold any of the Securities for any minimum period of time and reserves the right, subject to the provisions of the Notes, the Warrants, this Agreement and the Registration Rights Agreement, at
all times to sell or otherwise dispose of all or any part of such Securities pursuant to an effective registration statement under the Securities Act or under an exemption from such registration and in compliance with applicable federal and state
securities laws. Such Purchaser is acquiring the Securities hereunder in the ordinary course of its business. Such Purchaser does not presently have any agreement, plan or understanding, directly or indirectly, with any Person to distribute or
effect any distribution of any of the Securities (or any securities which are derivatives thereof) to or through any person or entity. The Purchaser is not a registered broker-dealer under Section 15 of the Exchange Act or an entity engaged in
a business that would require it to be so registered as a broker-dealer. 

 (d) Purchaser Status. At the time the Purchaser was offered the Securities, it was, and at
the date hereof it is, an “accredited investor” as defined in Rule 501(a) under the Securities Act. The Accredited Investor Questionnaire delivered by the Purchaser in connection with this Agreement is complete and accurate in all
respects as of the date of this Agreement and the Closing Date and will be accurate in all respects as of the effective date of the Registration Statement; provided, that the Purchaser shall be entitled to update such information prior to the
Closing by providing written notice thereof to the Company. 
 (e) General Solicitation. The Purchaser is not purchasing the
Securities as a result of any form of general solicitation or general advertising (within the meaning of Regulation D). 
 (f)
Experience. The Purchaser, either alone or together with its representatives, has such knowledge, sophistication and experience in business and financial matters so as to be capable of evaluating the merits and risks of the prospective
investment in the Securities, and has so evaluated the merits and risks of such investment. The Purchaser is able to bear the economic risk of an investment in the Securities and, at the present time, is able to afford a complete loss of such
investment. 
 (g) Access to Information. The Purchaser acknowledges that it has had the opportunity to review the Disclosure
Materials and has been afforded (i) the opportunity to ask such questions as it has deemed necessary of, and to receive answers from, representatives of the Company concerning the terms and conditions of the Offering and the merits and risks of
investing in the Securities, (ii) access to information about the Company and its Subsidiaries and their respective financial condition, results of operations, business, properties, management and prospects sufficient to enable it to evaluate
its investment, and (iii) the opportunity to obtain such additional information that the Company possesses or can acquire without unreasonable effort or expense that is necessary to make an informed investment decision with respect to the
investment. Neither such inquiries nor any other investigation conducted by or on behalf of the Purchaser or its representatives shall modify, amend or affect such Purchaser’s right to rely on the truth, accuracy and completeness of the
Disclosure Materials and the Company’s representations and warranties contained in the Transaction Documents. The Purchaser has sought such accounting, legal and tax advice as it has considered necessary to make an informed decision with
respect to its acquisition of the Securities. 
 (h) Certain Trading Activities. Other than consummating the transactions
contemplated hereunder, the Purchaser has not directly or indirectly, nor has any Person acting on behalf of or pursuant to any understanding with such Purchaser, engaged in any transactions in the securities of the Company (including, without
limitation, any Short Sales involving the Company’s securities) since the time that such Purchaser was first contacted by the Company, Maxim or any other Person regarding the specific investment contemplated hereby. Other than to (i) other
Persons party to this Agreement, (ii) Purchaser’s counsel, and (iii) those Persons previously disclosed by Purchaser to Maxim, such Purchaser has maintained the confidentiality of all disclosures made to it in connection with this
transaction, including the existence and terms of this transaction. 

 (i) Brokers and Finders. Other than Maxim with respect to the Company, no Person will
have, as a result of the transactions contemplated by this Agreement, any valid right, interest or claim against or upon the Company or any Purchaser for any commission, fee or other compensation pursuant to any agreement, arrangement or
understanding entered into by or on behalf of the Purchaser. 
 (j) Independent Investment Decision. The Purchaser has independently
evaluated the merits of its decision to purchase the Securities pursuant to the Transaction Documents, and such Purchaser confirms that it has not relied on the advice of any other Purchaser’s business and/or legal counsel in making such
decision. The Purchaser understands that nothing in this Agreement or any other materials presented by or on behalf of the Company to the Purchaser in connection with the purchase of the Securities constitutes legal, tax or investment advice. The
Purchaser has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with its purchase of the Securities. The Purchaser understands that Maxim has acted solely as the agent
of the Company in this placement of the Securities and such Purchaser has not relied on the business or legal advice of Maxim or any of its agents, counsel or Affiliates in making its investment decision hereunder, and the Purchaser confirms that
none of such Persons has made any representations or warranties to such Purchaser in connection with the transactions contemplated by the Transaction Documents. 

(k) Reliance on Exemptions. The Purchaser understands that the Securities are being offered and sold to it in reliance on specific
exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying in part upon the truth and accuracy of, and such Purchaser’s compliance with, the representations, warranties,
agreements, acknowledgements and understandings of such Purchaser set forth herein in order to determine the availability of such exemptions and the eligibility of such Purchaser to acquire the Securities. 

(l) No Governmental Review. The Purchaser understands that no United States federal or state agency or any other government or
governmental agency has passed on or made any recommendation or endorsement of the Securities or the fairness or suitability of the investment in the Securities nor have such authorities passed upon or endorsed the merits of the Offering. 

(m) Regulation M. The Purchaser is aware that the anti-manipulation rules of Regulation M under the Exchange Act may apply to
sales of Securities and other activities with respect to the Securities by the Purchasers. 
 (n) Residency. The Purchaser’s
residence (if an individual) or offices in which its investment decision with respect to the Securities was made (if an entity) are located at the address immediately below such Purchaser’s name on its signature page hereto. 

The Company and each of the Purchasers acknowledge and agree that no party to this Agreement has made or makes any representations or
warranties with respect to the transactions contemplated hereby other than those specifically set forth in this Agreement and the other Transaction Documents. 

 ARTICLE IV 

OTHER AGREEMENTS OF THE PARTIES 

4.1 Transfer Restrictions. 

(a) Compliance with Laws. Notwithstanding any other provision of this Article IV, each Purchaser covenants that the
Securities may be disposed of only pursuant to an effective registration statement under, and in compliance with the requirements of, the Securities Act, or pursuant to an available exemption from, or in a transaction not subject to, the
registration requirements of the Securities Act, and in compliance with any applicable state and federal securities laws. In connection with any transfer of the Securities other than (i) pursuant to an effective registration statement,
(ii) to the Company, (iii) pursuant to Rule 144 (provided that the Purchaser provides the Company with reasonable assurances (in the form of seller and, if applicable, broker representation letters) that the securities may be
sold pursuant to such rule) or (iv) in connection with a bona fide pledge as contemplated in Section 4.1(b), the Company may require the transferor thereof to provide to the Company an opinion of counsel selected by the transferor
and reasonably acceptable to the Company, the form and substance of which opinion shall be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities under the Securities
Act. As a condition of such transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement and the Registration Rights Agreement and shall have the rights of a Purchaser under this Agreement and the Registration
Rights Agreement with respect to such transferred Securities. 
 (b) Legends. Certificates or other instruments evidencing the
Securities shall bear any legend as required by the “blue sky” laws of any state and a restrictive legend in substantially the following form (and, with respect to Securities held in book-entry form, the Transfer Agent will record such a
legend on the share register), until such time as they are not required under Section 4.1(d): 
 THESE SECURITIES HAVE NOT BEEN
REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE
REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OR (B) AN AVAILABLE EXEMPTION FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND IN ACCORDANCE WITH APPLICABLE STATE SECURITIES
LAWS OR BLUE SKY LAWS AS EVIDENCED BY A LEGAL OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE COMPANY AND ITS TRANSFER AGENT OR (II) UNLESS SOLD PURSUANT TO RULE 144 UNDER THE SECURITIES ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES
MAY BE PLEDGED IN CONNECTION WITH A 

 
BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES. 

The Company acknowledges and agrees that a Purchaser may from time to time pledge, and/or grant a security interest in, some or all of the
legended Securities in connection with applicable securities laws, pursuant to a bona fide margin agreement in compliance with a bona fide margin loan. Such a pledge would not be subject to approval or consent of the Company and no legal opinion of
legal counsel to the pledgee, secured party or pledgor shall be required in connection with the pledge, but such legal opinion shall be required in connection with a subsequent transfer or foreclosure following default by the Purchaser transferee of
the pledge. No notice shall be required of such pledge, but Purchaser’s transferee shall promptly notify the Company of any such subsequent transfer or foreclosure. Each Purchaser acknowledges that the Company shall not be responsible for any
pledges relating to, or the grant of any security interest in, any of the Securities or for any agreement, understanding or arrangement between any Purchaser and its pledgee or secured party. At the applicable Purchaser’s expense, the Company
will execute and deliver such reasonable documentation as a pledgee or secured party of Securities may reasonably request in connection with a pledge or transfer of the Securities, including the preparation and filing of any required prospectus
supplement under Rule 424(b)(3) of the Securities Act or other applicable provision of the Securities Act to appropriately amend the list of selling stockholders thereunder. Each Purchaser acknowledges and agrees that, except as otherwise
provided in Section 4.1(d), any Securities subject to a pledge or security interest as contemplated by this Section 4.1(b) shall continue to bear the legend set forth in this Section 4.1(b) and be subject to the
restrictions on transfer set forth in Section 4.1(a). 
 (c) Transfer Agent Instructions. The Company represents and
warrants that no instruction other than stop transfer instructions to give effect to Section 4.1(a) will be given by the Company to its Transfer Agent with respect to the Underlying Shares, and that the Securities shall otherwise be
freely transferable on the books and records of the Company as and to the extent provided in this Agreement and the other Transaction Documents. If a Purchaser effects a sale, assignment, or transfer of the Underlying Shares in accordance with
Section 4.1(a), the Company shall permit the transfer and shall promptly instruct the Transfer Agent to issue one or more certificates or credit shares to the applicable balance accounts at DTC in such name and in such denominations as
specified by such Purchaser to effect such sale, transfer, or assignment. 
 (d) Removal of Legends. Certificates, instruments or
book-entry statements evidencing the Securities shall not be required to contain the legend set forth in Section 4.1(b) above or any other legend (i) while a registration statement (including a registration statement filed pursuant
to the Registration Rights Agreement) covering the resale of such Securities is effective under the 1933 Act, (ii) following any sale of such Securities pursuant to Rule 144 (assuming the transferor is not an Affiliate of the Company),
(iii) if such Securities are eligible to be sold, assigned or transferred under Rule 144 (provided that a Purchaser provides the Company with reasonable assurances that such Securities are eligible for sale, assignment or transfer under
Rule 144 which shall not include an opinion of counsel), (iv) in connection with a sale, assignment or other transfer (other than under Rule 144), provided that such Purchaser provides the Company with an opinion of counsel to such
Purchaser, in a generally acceptable form, to the effect that such sale, assignment or transfer of the Securities may be made without registration 

 
under the applicable requirements of the 1933 Act or (v) if such legend is not required under applicable requirements of the 1933 Act (including, without limitation, controlling judicial
interpretations and pronouncements issued by the SEC). If a legend is not required pursuant to the foregoing, the Company shall no later than five (5) Trading Days following the delivery by a Purchaser to the Company or the Transfer Agent (with
notice to the Company) of a legended certificate or instrument representing such Securities (endorsed or with stock powers attached, signatures guaranteed, and otherwise in form necessary to affect the reissuance and/or transfer, if applicable),
together with any other deliveries from such Purchaser as may be required above in this Section 4(d), as directed by such Purchaser, or, in the case of shares held in book-entry accounts, within five (5) Trading Days following the
date on which a legend is no longer required, without any action required on the part of the Purchaser, either: (A) provided that the Company’s transfer agent is participating in the DTC Fast Automated Securities Transfer Program, credit
the aggregate number of Securities to which such Purchaser shall be entitled to such Purchaser’s or its designee’s balance account with DTC through its Deposit/Withdrawal at Custodian system or (B) if the Company’s Transfer Agent
is not participating in the DTC Fast Automated Securities Transfer Program, issue and deliver (via reputable overnight courier) to such Purchaser, a certificate or instrument representing such Securities that is free from all restrictive and other
legends, registered in the name of such Purchaser or its designee (the date by which such credit is so required to be made to the balance account of such Purchaser’s or such Purchaser’s nominee with DTC or such certificate is required to
be delivered to such Purchaser pursuant to the foregoing is referred to herein as the “Required Delivery Date”). The Company shall be responsible for any transfer agent fees or DTC fees with respect to any issuance of Securities or
the removal of any legends with respect to any Securities in accordance herewith. 
 (e) Breach. The Company acknowledges that a
breach by it of its obligations hereunder will cause irreparable harm to a Purchaser. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations under this Section 4.1 will be inadequate and agrees, in the
event of a breach or threatened breach by the Company of the provisions of this Section 4.1, that a Purchaser shall be entitled, in addition to all other available remedies, to an order and/or injunction restraining any breach and requiring
immediate issuance and transfer, without the necessity of showing economic loss and without any bond or other security being required. 

(f) Additional Relief. If the Company shall fail for any reason or for no reason to issue to such holder unlegended certificates or to
credit the Purchaser’s DTC account with unrestricted shares within five (5) Trading Days following the satisfaction of the conditions for the removal of legend set forth above (the “Deadline Date”), then, in addition to
all other remedies available to the holder, if on or after the Trading Day immediately following such five (5) Trading Day period, the holder purchases (in an open market transaction or otherwise) Securities to deliver in satisfaction of a sale
by the holder of Securities that the holder anticipated receiving without legend from the Company (a “Buy-In”), then the Company shall, within three (3) Trading Days after the holder’s request and in the holder’s discretion,
either (i) pay cash to the holder in an amount equal to the holder’s total purchase price (including brokerage commissions, if any) for the Securities so purchased (the “Buy-In Price”), at which point the Company’s
obligation to deliver such certificate (and to issue such Securities) shall terminate, or (ii) promptly honor its obligation to deliver to the holder a certificate or certificates representing such Securities and pay cash to the holder in an
amount equal to the excess (if any) of the Buy-In 

 
Price over the product of (A) the number of such Securities, times (B) the Closing Bid Price on the Deadline Date. “Closing Bid Price” means, for any security as of any
date, the last closing price for such security on The NASDAQ Stock Market (any market tier) (the “Principal Market”), as reported by Bloomberg, or, if the Principal Market begins to operate on an extended hours basis and does not
designate the closing bid price then the last bid price of such security prior to 4:00:00 p.m., Eastern Time, as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or trading market for such security,
the last closing price of such security on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the foregoing do not apply, the last closing price of such security in the
over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, or, if no closing bid price is reported for such security by Bloomberg, the average of the bid prices of any market makers for such security as
reported in the OTC Pink (also known as “Pink Sheets”) by OTC Markets Group Inc. (or any similar organization or agency succeeding to its functions of reporting prices). If the Closing Bid Price cannot be calculated for a security on a
particular date on any of the foregoing bases, the Closing Bid Price of such security on such date shall be the fair market value as mutually determined by the Company and the holder. If the Company and the holder are unable to agree upon the fair
market value of such security, then such dispute shall be resolved pursuant to the procedure that follows. The Company shall submit the disputed determinations or arithmetic calculations of the Closing Bid Price via facsimile within five (5)
Business Days after the Deadline Date (if the Company did not otherwise deliver unlegended certificates pursuant to this Section 4) to the Holder. If the Holder and the Company are unable to agree upon such determination or calculation of the
Closing Bid Price within five (5) Business Days of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within five (5) Business Days submit via facsimile the disputed determination
of the Closing Bid Price to an independent, reputable investment bank selected by the Company and approved by the Holder. The Company shall cause at its expense the investment bank to perform the determinations or calculations and notify the Company
and the Holder of the results no later than ten (10) Business Days from the time it receives the disputed determinations or calculations. Such investment bank’s determination or calculation shall be binding upon all parties absent
demonstrable error. All such determinations shall be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction during the applicable calculation period. 

(g) Acknowledgement. Each Purchaser hereunder acknowledges its primary responsibilities under the Securities Act and accordingly will
not sell or otherwise transfer the Securities or any interest therein without complying with the requirements of the Securities Act. While the Registration Statement remains effective, each Purchaser hereunder may sell the Securities only in
accordance with the plan of distribution contained in the Registration Statement and if it does so it will comply therewith and with the related prospectus delivery requirements unless an exemption therefrom is available or unless the Securities are
sold pursuant to Rule 144. Each Purchaser, severally and not jointly with the other Purchasers, agrees that if it is notified by the Company in writing at any time that the Registration Statement registering the resale of the Underlying Shares
is not effective or that the prospectus included in such Registration Statement no longer complies with the requirements of Section 10 of the Securities Act, the Purchaser will refrain from selling such Underlying Shares until such time as the
Purchaser is notified by the Company that such Registration Statement is effective or such prospectus is compliant with Section 10 of the Securities Act, unless such Purchaser is able to, 

 
and does, sell such Underlying Shares pursuant to an available exemption from the registration requirements of Section 5 of the Securities Act or unless the Securities are sold pursuant to
Rule 144. Both the Company and its Transfer Agent, and their respective directors, officers, employees and agents, may rely on this Section 4.1(g) and each Purchaser hereunder will indemnify and hold harmless each of such persons from
any breaches or violations of this Section 4.1(g). 
 4.2 Furnishing of Information. In order to enable the Purchasers to
sell the Securities under Rule 144, for a period of one year from the Closing Date, the Company shall use its commercially reasonable efforts to timely file (or obtain extensions in respect thereof and file within the applicable grace period)
all reports required to be filed by the Company after the date hereof pursuant to the Exchange Act. If the Company is not required to file reports pursuant to the Exchange Act during such period, it will prepare and furnish to the Purchasers and
make publicly available in accordance with Rule 144(c) such information as is required for the Purchasers to sell the Securities under Rule 144. 

4.3 No Integration. The Company shall not, and shall use its commercially reasonable efforts to ensure that no Affiliate of the Company
shall, sell, offer for sale or solicit offers to buy or otherwise negotiate in respect of any security (as defined in Section 2 of the Securities Act) that will be integrated with the offer or sale of the Securities in a manner that would
require the registration under the Securities Act of the sale of the Securities to the Purchasers, or that will be integrated with the offer or sale of the Securities for purposes of the rules and regulations of any Trading Market such that it would
require stockholder approval prior to the closing of such other transaction unless stockholder approval is obtained before the closing of such subsequent transaction. 

4.4 Securities Laws Disclosure; Publicity. The Company shall issue a press release disclosing the material terms of the transactions
contemplated hereby (the “Press Release”) no later than 9:00 A.M., Eastern time, on the Trading Day immediately following Offering Termination Date. In addition, the Company shall file a Current Report on Form 8-K with the
Commission describing the terms of the Transaction Documents (and including as exhibits to such Current Report on Form 8-K this Agreement, and the Registration Rights Agreement) within the time prescribed by the Exchange Act. Notwithstanding
the foregoing, the Company shall not publicly disclose the name of any Purchaser or any Affiliate or investment adviser of any Purchaser, or include the name of any Purchaser or any Affiliate or investment adviser of any Purchaser in any press
release or filing with the Commission (other than the Registration Statement) or any regulatory agency or Trading Market without the prior written consent of such Purchaser, except (i) as required by federal securities law in connection with
(A) any registration statement contemplated by the Registration Rights Agreement or (B) the filing of Transaction Documents (including signature pages thereto) with the Commission or (ii) to the extent such disclosure is otherwise
required by law, request of the Staff of the Commission or Trading Market regulations. From and after the issuance of the Press Release, no Purchaser shall be in possession of any material, non-public information received from the Company, any
Subsidiary or any of their respective officers, directors, employees or agents, that is not disclosed in the Press Release unless a Purchaser shall have executed a written agreement regarding the confidentiality and use of such information. 

 4.5 Confidentiality. Each Purchaser, severally and not jointly with the other Purchasers,
covenants that, until such time as the transactions contemplated by this Agreement are publicly disclosed by the Company as described in Section 4.4, (i) such Purchaser shall maintain the confidentiality of all disclosures made to
it in connection with this transaction, including the existence and terms of this transaction and the information included in the Transaction Documents and Disclosure Schedules, and (ii) neither such Purchaser nor any Person acting on its
behalf or pursuant to any understanding with it shall engage in any purchase or sale of securities of the Company (including Short Sales). Notwithstanding the preceding clause (ii), in the case of a Purchaser that is a multi-managed investment
vehicle whereby separate portfolio managers manage separate portions of such Purchaser’s assets and the portfolio managers have no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such
Purchaser’s assets, the covenant set forth above shall apply only with respect to the portion of assets managed by the portfolio manager that has knowledge about the financing transaction contemplated by this Agreement. 

4.6 Non-Public Information. Except with respect to the material terms and conditions of the transactions contemplated by the
Transaction Documents, including this Agreement, the Company covenants and agrees that neither it, nor any other Person acting on its behalf, will provide any Purchaser or its agents or counsel with any information regarding the Company that the
Company believes constitutes material non-public information without the express written consent of such Purchaser, unless prior thereto such Purchaser shall have executed a written agreement regarding the confidentiality and use of such
information. The Company understands and confirms that each Purchaser shall be relying on the foregoing covenant in effecting transactions in securities of the Company. 

4.7 Indemnification of Purchasers. 

(a) Subject to the provisions of this Section 4.7, the Company will indemnify and hold each Purchaser, such Purchaser’s
directors, officers, shareholders, members, partners, investment adviser, employees and agents (and any other Persons with a functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title), each
Person who controls such Purchaser (within the meaning of Section 15 of the Securities Act and Section 20 of the Exchange Act), and the directors, officers, shareholders, agents, members, partners or employees (and any other Persons with a
functionally equivalent role of a Person holding such titles notwithstanding a lack of such title or any other title) of such controlling persons (each, a “Purchaser Party”), harmless from any and all losses, liabilities,
obligations, claims, contingencies, damages, costs and expenses, including all judgments, amounts paid in settlements, court costs and reasonable attorneys’ fees and costs of investigation that any such Purchaser Party may suffer or incur as a
result of or relating to (a) any breach of any of the representations, warranties, covenants or agreements made by the Company in this Agreement or in the other Transaction Documents or (b) any action instituted against a Purchaser in any
capacity, or any other Purchaser Party, by any stockholder of the Company who is not an Affiliate of such Purchaser, with respect to any of the transactions contemplated by the Transaction Documents (unless such action is based upon a breach of such
Purchaser’s representations, warranties or covenants under any of the Transaction Documents or any agreements or understandings such Purchaser may have with any such stockholder or any willful violations by the Purchaser of any applicable laws
or any conduct by such Purchaser which constitutes fraud, willful misconduct or malfeasance). 

 (b) Promptly after receipt by any Purchaser Party (the “Indemnified Person”) of
notice of any demand, claim or circumstances which would or might give rise to a claim or the commencement of any action, proceeding or investigation in respect of which indemnity may be sought pursuant to this Section 4.7, such
Indemnified Person shall promptly notify the Company in writing and the Company shall assume the defense thereof, including the employment of counsel reasonably satisfactory to such Indemnified Person, and shall assume the payment of all fees and
expenses relating to such action, proceeding or investigation; provided, however, that the failure of any Indemnified Person so to notify the Company shall not relieve the Company of its obligations hereunder except to the extent that
the Company is actually and materially prejudiced by such failure to notify. In any such proceeding, any Indemnified Person shall have the right to retain its own counsel, but the fees and expenses of such counsel shall be at the expense of such
Indemnified Person unless: (i) the Company and the Indemnified Person shall have mutually agreed to the retention of such counsel; (ii) the Company shall have failed promptly to assume the defense of such proceeding and to employ counsel
reasonably satisfactory to such Indemnified Person in such proceeding; or (iii) in the reasonable judgment of counsel to such Indemnified Person, representation of both parties by the same counsel would be inappropriate due to actual or
potential differing interests between them, in which case the Company shall be responsible for the reasonable fees and expenses of no more than one such separate counsel. The Company shall not be liable for any settlement of any proceeding effected
without its written consent, which consent shall not be unreasonably withheld, delayed or conditioned. Without the prior written consent of the Indemnified Person, which consent shall not be unreasonably withheld, delayed or conditioned, the Company
shall not effect any settlement of any pending or threatened proceeding in respect of which any Indemnified Person is or could have been a party and indemnity could have been sought hereunder by such Indemnified Party, unless such settlement
includes an unconditional release of such Indemnified Person from all liability arising out of such proceeding. 
 4.8 Principal Trading
Market Listing. If necessary, the Company shall prepare and file with the Principal Trading Market an additional shares listing application covering all of the Underlying Shares and shall use its commercially reasonable efforts to take all steps
necessary to cause all of the Underlying Shares to be approved for listing or quotation on the Principal Trading Market as promptly as possible thereafter. 

4.9 Form D; Blue Sky. The Company agrees to timely file a Form D with respect to the Securities as required under
Regulation D and to provide a copy thereof to any Purchaser, promptly upon such Purchaser’s written request. The Company shall take such action as the Company shall reasonably determine is necessary in order to qualify the Securities for
sale at the Closing to the Purchasers, or to obtain an exemption from such qualification, under applicable state securities or “blue sky” laws, and the Company shall provide evidence of such actions promptly upon the written request of any
Purchaser. 
 4.10 Additional Director. In the event that the Current Value of a share of the Company’s Common Stock on December
    , 2014 is less than $4.50, the Company and Bulldog Investors, LLC, as representative of the Purchasers, agree to use their best efforts to identify and 

 
appoint a new, mutually-acceptable member of the Company’s Board of Directors. The Purchasers hereby consent to the appointment of Bulldog Investors, LLC as the representative of the
Purchasers solely for the purpose of this Section 4.10. 
 4.11 Right of Participation. The Company hereby grants each Purchaser
the right to purchase their pro rata percentage of an aggregate of $10 million of securities in the first firmly underwritten public offering of the Company’s equity or debt completed subsequent to the date of this Agreement (the
“Subsequent Offering”). The securities offered to each Purchaser will be offered on the same terms as the Company may propose to sell the securities to a third party. Each Purchaser’s pro rata percentage shall be based upon the
proportion that the investment made by the Purchaser in the transaction contemplated by this Agreement bears to the total size of the transaction. The Purchaser must exercise the right of participation within five business days of notice from the
Company. 
 4.12 The Company shall provide each shareholder entitled to vote at a special or annual meeting of shareholders of the
Company (the “Shareholder Meeting”), which shall be called and held not later than six months following the Closing (the “Shareholder Approval Date”), a proxy statement, containing a shareholder vote solicitation
section, soliciting each such shareholder’s affirmative vote at the Shareholder Meeting for approval of resolutions (the “Resolutions”) providing for the issuance of Underlying Shares in excess of 19.9% of the number of the
Company’s issues and outstanding shares of Common Stock on the date of this Agreement (the “Shareholder Matter”) in accordance with applicable law and NASDAQ Marketplace Rule 4350(i) (such affirmative approval being referred to
herein as the “Shareholder Approval”), and the Company shall use its reasonable best efforts to solicit the Shareholder Approval of the Resolutions and to cause the Board of Directors of the Company to recommend to the shareholders
that they approve the Resolutions. The Company shall be obligated to seek to obtain the Shareholder Approval by the Shareholder Approval Date.  

ARTICLE V 
 CONDITIONS
PRECEDENT TO CLOSING 
 5.1 Conditions Precedent to the Obligations of the Purchasers to Purchase Securities. The obligation
of each Purchaser to acquire the Securities at the Closing is subject to the fulfillment, on or prior to the Closing Date, of each of the following conditions, any of which may be waived by such Purchaser (as to itself only): 

(a) Representations and Warranties. The representations and warranties of the Company contained herein shall be true and correct in all
material respects (except for those representations and warranties which are qualified as to materiality, in which case such representations and warranties shall be true and correct in all respects) as of the date when made and as of the Closing
Date, as though made on and as of such date, except for such representations and warranties that speak as of a specific date. 
 (b)
Performance. The Company shall have performed, satisfied and complied in all material respects with any and all covenants, agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by it at or
prior to the Closing. 

 (c) No Injunction. No statute, rule, regulation, executive order, decree, ruling or
injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction Documents. 

(d) No Material Adverse Effect. Since the date of execution of this Agreement, no event or series of events shall have occurred that
has had a Material Adverse Effect. 
 (e) No Suspensions of Trading in Common Stock. The Common Stock (i) shall be designated
for listing or quotation on the Principal Trading Market and (ii) shall not have been suspended, as of the Closing Date, by the Commission or the Principal Trading Market from trading on the Principal Trading Market nor shall suspension by the
Commission or the Principal Trading Market have been threatened, as of the Closing Date, either (A) in writing by the Commission or the Principal Trading Market or (B) by falling below any minimum listing maintenance requirements of the
Principal Trading Market. 
 (f) Company Deliverables. The Company shall have delivered the Company Deliverables in
accordance with    Section 2.2(a). 
 5.2 Conditions Precedent to the Obligations of the Company to sell
Securities. The Company’s obligation to sell and issue the Securities at the Closing to each Purchaser is subject to the fulfillment on or prior to the Closing Date of the following conditions, any of which may be waived by the Company:

 (a) Representations and Warranties. The representations and warranties made by the Purchaser in Section 3.2 hereof
shall be true and correct in all material respects (except for those representations and warranties which are qualified as to materiality, in which case such representations and warranties shall be true and correct in all respects) as of the date
when made, and as of the Closing Date as though made on and as of such date, except for representations and warranties that speak as of a specific date. 

(b) Performance. The Purchaser shall have performed, satisfied and complied in all material respects with any and all covenants,
agreements and conditions required by the Transaction Documents to be performed, satisfied or complied with by such Purchaser at or prior to the Closing Date. 

(c) No Injunction. No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered,
promulgated or endorsed by any court or governmental authority of competent jurisdiction that prohibits the consummation of any of the transactions contemplated by the Transaction Documents. 

(d) Purchaser Deliverables. The Purchaser shall have delivered its Purchaser Deliverables in accordance with     
Section 2.2(b). 

 ARTICLE VI 

MISCELLANEOUS 
 6.1
Fees and Expenses. The Company shall pay the fees and expenses of its and the Purchasers’ respective advisers, counsel, accountants and other experts, if any, and all other expenses incurred by such party in connection with the
negotiation, preparation, execution, delivery and performance of this Agreement. The Company’s maximum liability for the fees and expenses of the Purchasers referenced in the prior sentence shall be $25,000. The Company shall pay all Transfer
Agent fees, stamp taxes and other taxes and duties levied in connection with the sale and issuance of the Securities to the Purchasers. 

6.2 Entire Agreement. The Transaction Documents, together with the exhibits and schedules thereto, contain the entire understanding of
the parties with respect to the subject matter hereof and supersede all prior agreements, understandings, discussions and representations, oral or written, with respect to such matters, which the parties acknowledge have been merged into such
documents, exhibits and schedules. At or after the Closing, and without further consideration, the Company and the Purchasers will execute and deliver to the other such further documents as may be reasonably requested in order to give practical
effect to the intention of the parties under the Transaction Documents. 
 6.3 Notices. Any and all notices or other communications
or deliveries required or permitted to be provided hereunder shall be in writing and shall be deemed given and effective on the earliest of (a) the date of transmission, if such notice or communication is delivered via facsimile (provided the
sender receives a machine-generated confirmation of successful transmission) at the facsimile number specified in this Section 6.3 prior to 5:00 P.M., Eastern time, on a Trading Day, (b) the next Trading Day after the date of
transmission, if such notice or communication is delivered via facsimile at the facsimile number specified in this Section 6.3 on a day that is not a Trading Day or later than 5:00 P.M., Eastern time, on any Trading Day,
(c) the Trading Day following the date of mailing, if sent by U.S. nationally recognized overnight courier service with next day delivery specified, or (d) upon actual receipt by the party to whom such notice is required to be given, if
such notice or communication is delivered via electronic mail or any other method not identified in the preceding clauses (a) - (c). The address for such notices and communications shall be as follows: 

 

			
	If to the Company:	 	Wheeler Real Estate Investment Trust, Inc.
		 	2529 Virginia Beach Boulevard, Suite 200
		 	Virginia Beach, VA 23452
		 	Telephone No.: (757) 627-9088
		 	Facsimile No.: (757) 627-9081
		 	Attention: Steven M. Belote
		 	E-mail: steven@whlr.us
		
	With a copy to:	 	Kaufman & Canoles, P.C.
		 	1021 East Cary Street, Suite 1400
		 	Richmond, VA 23219
		 	Telephone No.: (804) 771-5790
		 	Facsimile No.: (804) 771-5777
		 	Attention: Bradley A. Haneberg
		 	E-mail: bahaneberg@kaufcan.com

			
	If to a Purchaser:	 	To the address set forth under such Purchaser’s name on the signature page hereof
		
	With a copy to:	 	Stephanie Darling
		 	The Law Office of Stephanie Darling
		 	818 Ridge Road
		 	Rising Sun, MD 21911

 or such other address as may be designated in writing hereafter, in the same manner, by such Person. 

6.4 Amendments; Waivers; No Additional Consideration. No provision of this Agreement may be waived, modified, supplemented or amended
except in a written instrument signed, in the case of an amendment, by the Company and Required Purchasers at the time of the amendment (which amendment shall be binding on all Purchasers) or, in the case of a waiver, by the party against whom
enforcement of any such waiver provision is sought. No waiver of any default with respect to any provision, condition or requirement of this Agreement shall be deemed to be a continuing waiver in the future or a waiver of any subsequent default or a
waiver of any other provision, condition or requirement hereof, nor shall any delay or omission of either party to exercise any right hereunder in any manner impair the exercise of any such right. No consideration shall be offered or paid to any
Purchaser to amend or consent to a waiver or modification of any provision of this Agreement unless the same consideration is also offered to all Purchasers who then hold Securities. 

6.5 Construction. The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to
limit or affect any of the provisions hereof. The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent, and no rules of strict construction will be applied against any party. This
Agreement shall be construed as if drafted jointly by the parties, and no presumption or burden of proof shall arise favoring or disfavoring any party by virtue of the authorship of any provisions of this Agreement or any other Transaction
Documents. 
 6.6 Successors and Assigns. The provisions of this Agreement shall inure to the benefit of and be binding upon the
parties and their successors and permitted assigns. This Agreement, or any rights or obligations hereunder, may not be assigned by the Company without the prior written consent of the Required Purchasers at that time, except in the event of a merger
or in connection with another entity acquiring all or substantially all of the Company’s assets. Any Purchaser may assign its rights hereunder in whole or in part to any Person to whom such Purchaser assigns or transfers any Securities in
compliance with the Transaction Documents and applicable law, provided such transferee shall agree in writing to be bound, with respect to the transferred Securities, by the terms and conditions of this Agreement that apply to the
“Purchasers.” 

 6.7 No Third-Party Beneficiaries. This Agreement is intended for the benefit of the
parties hereto and their respective successors and permitted assigns and is not for the benefit of, nor may any provision hereof be enforced by, any other Person, except each Purchaser Party is an intended third party beneficiary of
Section 4.7. 
 6.8 Governing Law. All questions concerning the construction, validity, enforcement and interpretation of
this Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of New York, without regard to the principles of conflicts of law thereof. Each party agrees that all Proceedings concerning the
interpretation, enforcement and defense of the transactions contemplated by this Agreement and any other Transaction Documents (whether brought against a party hereto or its respective Affiliates, employees or agents) shall be commenced exclusively
in the New York Courts. Each party hereto hereby irrevocably submits to the exclusive jurisdiction of the New York Courts for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or
discussed herein (including with respect to the enforcement of any of the Transaction Documents), and hereby irrevocably waives, and agrees not to assert in any Proceeding, any claim that it is not personally subject to the jurisdiction of any such
New York Court, or that such Proceeding has been commenced in an improper or inconvenient forum. Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such Proceeding by mailing a copy
thereof via registered or certified mail or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of
process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. EACH PARTY HERETO HEREBY IRREVOCABLY WAIVES, TO THE FULLEST EXTENT PERMITTED BY APPLICABLE LAW,
ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATING TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY. 

6.9 Survival. Subject to applicable statute of limitations, the representations, warranties, agreements and covenants contained herein
shall survive the Closing and the delivery of the Securities pursuant to the Closing. 
 6.10 Execution. This Agreement may be
executed in two or more counterparts, all of which when taken together shall be considered one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood
that the parties need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission, or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of
the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature page were an original thereof. 

6.11 Severability. If any provision of this Agreement is held to be invalid or unenforceable in any respect, the validity and
enforceability of the remaining terms and provisions of this Agreement shall not in any way be affected or impaired thereby and the parties will attempt to agree upon a valid and enforceable provision that is a reasonable substitute therefor, and
upon so agreeing, shall incorporate such substitute provision in this Agreement. 

 6.12 Rescission and Withdrawal Right. Notwithstanding anything to the contrary contained
in (and without limiting any similar provisions of) the Transaction Documents, whenever any Purchaser exercises a right, election, demand or option under a Transaction Document and the Company does not timely perform its related obligation within
the period therein provided, then such Purchaser may, in its sole discretion, rescind or withdraw any such notice, demand or election in whole or in part, without prejudice to its future actions and rights, upon written notice to the Company prior
to the Company’s performance of the related obligation. 
 6.13 Replacement of Securities. If any certificate or instrument
evidencing any Securities is mutilated, lost, stolen or destroyed, the Company shall issue or cause to be issued in exchange and substitution for and upon cancellation thereof, or in lieu of and substitution therefor, a new certificate or
instrument, but only upon receipt of evidence reasonably satisfactory to the Company and the Transfer Agent of such loss, theft or destruction and the execution by the holder thereof of a customary lost certificate affidavit of that fact or, if
required by the Transfer Agent, a bond in such form and amount as is required by the Transfer Agent. To the extent a certificate was properly delivered to, and received by, a Purchaser, , the cost of any such bond shall be borne by the Purchaser. To
the extent the certificate was not properly delivered to, and received by, the Purchaser, the cost of any such bond shall be borne by the Company. If a replacement certificate or instrument evidencing any Securities is requested due to a mutilation
thereof, the Company may require delivery of such mutilated certificate or instrument as a condition precedent to any issuance of a replacement. 

6.14 Remedies. In addition to being entitled to exercise all rights provided herein or granted by law, including recovery of damages,
each of the Purchasers and the Company will be entitled to specific performance under the Transaction Documents. The parties agree that monetary damages may not be adequate compensation for any loss incurred by reason of any breach of obligations
described in the foregoing sentence and hereby agree to waive in any action for specific performance of any such obligation (other than in connection with any action for a temporary restraining order) the defense that a remedy at law would be
adequate. 
 6.15 Payment Set Aside. To the extent that the Company makes a payment or payments to any Purchaser pursuant to any
Transaction Document or a Purchaser enforces or exercises its rights thereunder, and such payment or payments or the proceeds of such enforcement or exercise or any part thereof are subsequently invalidated, declared to be fraudulent or
preferential, set aside, recovered from, disgorged by or are required to be refunded, repaid or otherwise restored to the Company, a trustee, receiver or any other Person under any law (including, without limitation, any bankruptcy law, state or
federal law, common law or equitable cause of action), then to the extent of any such restoration the obligation or part thereof originally intended to be satisfied shall be revived and continued in full force and effect as if such payment had not
been made or such enforcement or setoff had not occurred. 
 6.16 Additional Closings. Each Purchaser acknowledges that, in addition
to the Closing, the Company may hold one or more other closings for the purchase and sale of Securities in the Offering, whether before and/or after the Closing Date; provided, that the Final Closing Date must be on or prior to the Offering
Termination Date. 

 6.17 Independent Nature of Purchasers’ Obligations and Rights. The obligations of
each Purchaser under any Transaction Document are several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance of the obligations of any other Purchaser under any Transaction
Document. The decision of each Purchaser to purchase Securities pursuant to the Transaction Documents has been made by such Purchaser independently of any other Purchaser and independently of any information, materials, statements or opinions as to
the business, affairs, operations, assets, properties, liabilities, results of operations, condition (financial or otherwise) or prospects of the Company or any Subsidiary which may have been made or given by any other Purchaser or by any agent or
employee of any other Purchaser, and no Purchaser and none of its agents or employees shall have any liability to any other Purchaser (or any other Person) relating to or arising from any such information, materials, statements or opinions. Nothing
contained herein or in any other Transaction Document, and no action taken by any Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or
create a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions contemplated by the Transaction Documents. Each Purchaser acknowledges that no other Purchaser has acted as
agent for such Purchaser in connection with making its investment hereunder and that no Purchaser will be acting as agent of such Purchaser in connection with monitoring its investment in the Securities or enforcing its rights under the Transaction
Documents. Each Purchaser shall be entitled to independently protect and enforce its rights, including without limitation the rights arising out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other
Purchaser to be joined as an additional party in any Proceeding for such purpose. It is expressly understood and agreed that each provision contained in this Agreement is between the Company and a Purchaser, solely, and not between the Company and
the Purchasers collectively and not between and among the Purchasers. 

 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

IN WITNESS WHEREOF, the parties hereto have caused this Securities Purchase Agreement to be duly executed as of the date first indicated above. 

 

			
	WHEELER REAL ESTATE INVESTMENT TRUST, INC.
		
	By:	 	 /s/ Jon S.Wheeler

		 	Jon S. Wheeler
		 	Chairman and Chief Executive Officer

 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

 [PURCHASER SIGNATURE PAGE TO SECURITIES PURCHASE AGREEMENT] 

Aggregate Principal Amount of Convertible Notes to be Acquired: $1,410,000 

Aggregate Principal Amount of Non-Convertible Notes to be Acquired: $940,000 

Number of Warrant Shares to be Acquired: 98,947 

Aggregate Purchase Price (Subscription Amount): $2,350,000 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

									
		 		 	
	  
	 		 	  

	Print Name(s)	 		 	Social Security Number(s)
			
		 		 	
	  
	 		 	  

	Signature(s) of Purchaser(s)	 		 	Signature(s) of Purchaser(s)
			
	Address:	 		 	
			
	  
	 		 	
			
	  
	 		 	
			
	  
	 		 	
					
	Telephone:	 	  
	 		 	Fax:	 	  

					
	Email:	 	  
	 		 		 	

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

									
	Opportunity Partners, L.P.	 		 	
	  
	 		 	  

	Name of Entity	 		 	Federal Taxpayer ID Number
				
	By:	 	 /s/ Andrew Dakos
	 		 	 Ohio

	Name:	 	 Andrew Dakos
	 		 	State of Organization
	Title:	 	 Manager – Bulldog Investors, LLC
	 		 	
			
	Address:	 		 	
			
	 Bulldog Investors, LLC
	 		 	
			
	 Park 80 West – Plaza Two
	 		 	
			
	 250 Pehle Avenue, Suite 708
	 		 	
			
	 Saddle Brook, NJ 07663
	 		 	
					
	Telephone:	 	 201-881-7101
	 		 	Fax:	 	 201-556-0097

			
	Email: adakos@bulldoginvestors.com	 		 	

 [PURCHASER SIGNATURE PAGE TO SECURITIES PURCHASE AGREEMENT] 

Aggregate Principal Amount of Convertible Notes to be Acquired: $150,000 

Aggregate Principal Amount of Non-Convertible Notes to be Acquired: $100,000 

Number of Warrant Shares to be Acquired: 10,526 

Aggregate Purchase Price (Subscription Amount): $250,000 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

									
		 		 	
	  
	 		 	  

	Print Name(s)	 		 	Social Security Number(s)
			
		 		 	
	  
	 		 	  

	Signature(s) of Purchaser(s)	 		 	Signature(s) of Purchaser(s)
			
	Address:	 		 	
			
	  
	 		 	
			
	  
	 		 	
			
	  
	 		 	
					
	Telephone:	 	  
	 		 	Fax:	 	  

					
	Email:	 	  
	 		 		 	

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

									
	MCM Opportunity Partners, L.P.	 		 	
	  
	 		 	  

	Name of Entity	 		 	Federal Taxpayer ID Number
				
	By:	 	 /s/ Andrew Dakos
	 		 	 Delaware

	Name:	 	 Andrew Dakos
	 		 	State of Organization
	Title:	 	 Manager – Bulldog Investors, LLC
	 		 		 	
			
	Address:	 		 	
			
	 Bulldog Investors, LLC
	 		 	
			
	 Park 80 West – Plaza Two
	 		 	
			
	 250 Pehle Avenue, Suite 708
	 		 	
			
	 Saddle Brook, NJ 07663
	 		 	
					
	Telephone:	 	 201-881-7101
	 		 	Fax:	 	 201-556-0097

			
	Email: adakos@bulldoginvestors.com	 		 	

 [PURCHASER SIGNATURE PAGE TO SECURITIES PURCHASE AGREEMENT] 

Aggregate Principal Amount of Convertible Notes to be Acquired: $1,200,000 

Aggregate Principal Amount of Non-Convertible Notes to be Acquired: $800,000 

Number of Warrant Shares to be Acquired: 84,211 

Aggregate Purchase Price (Subscription Amount): $2,000,000 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

									
		 		 	
	  
	 		 	  

	Print Name(s)	 		 	Social Security Number(s)
			
		 		 	
	  
	 		 	  

	Signature(s) of Purchaser(s)	 		 	Signature(s) of Purchaser(s)
			
	Address:	 		 	
			
	  
	 		 	
			
	  
	 		 	
			
	  
	 		 	
					
	Telephone:	 	  
	 		 	Fax:	 	  

					
	Email:	 	  
	 		 		 	

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

									
	Special Opportunities Fund, Inc.	 		 	
	  
	 		 	  

	Name of Entity	 		 	Federal Taxpayer ID Number
				
	By:	 	 /s/ Andrew Dakos
	 		 	 Maryland

	Name:	 	 Andrew Dakos
	 		 	State of Organization
	Title:	 	 Manager – Bulldog Investors, LLC
	 		 		 	
			
	Address:	 		 	
			
	 Bulldog Investors, LLC
	 		 	
			
	 Park 80 West – Plaza Two
	 		 	
			
	 250 Pehle Avenue, Suite 708
	 		 	
			
	 Saddle Brook, NJ 07663
	 		 	
					
	Telephone:	 	 201-881-7101
	 		 	Fax:	 	 201-556-0097

			
	Email: adakos@bulldoginvestors.com	 		 	

 [PURCHASER SIGNATURE PAGE TO SECURITIES PURCHASE AGREEMENT] 

Aggregate Principal Amount of Convertible Notes to be Acquired: $480,000 

Aggregate Principal Amount of Non-Convertible Notes to be Acquired: $320,000 

Number of Warrant Shares to be Acquired: 33,684 

Aggregate Purchase Price (Subscription Amount): $800,000 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

									
		 		 	
	  
	 		 	  

	Print Name(s)	 		 	Social Security Number(s)
			
		 		 	
	  
	 		 	  

	Signature(s) of Purchaser(s)	 		 	Signature(s) of Purchaser(s)
			
	Address:	 		 	
			
	  
	 		 	
			
	  
	 		 	
			
	  
	 		 	
					
	Telephone:	 	  
	 		 	Fax:	 	  

					
	Email:	 	  
	 		 		 	

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

									
	Mercury Partners, L.P.	 		 	
	  
	 		 	  

	Name of Entity	 		 	Federal Taxpayer ID Number
				
	By:	 	 /s/ Andrew Dakos
	 		 	 Delaware

	Name:	 	 Andrew Dakos
	 		 	State of Organization
	Title:	 	 Manager – Bulldog Investors, LLC
	 		 		 	
			
	Address:	 		 	
			
	 Bulldog Investors, LLC
	 		 	
			
	 Park 80 West – Plaza Two
	 		 	
			
	 250 Pehle Avenue, Suite 708
	 		 	
			
	 Saddle Brook, NJ 07663
	 		 	
					
	Telephone:	 	 201-881-7101
	 		 	Fax:	 	 201-556-0097

			
	Email: adakos@bulldoginvestors.com	 		 	

 [PURCHASER SIGNATURE PAGE TO SECURITIES PURCHASE AGREEMENT] 

Aggregate Principal Amount of Convertible Notes to be Acquired: $1,350,000 

Aggregate Principal Amount of Non-Convertible Notes to be Acquired: $900,000 

Number of Warrant Shares to be Acquired: 94,737 

Aggregate Purchase Price (Subscription Amount): $2,250,000 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

									
		 		 	
	  
	 		 	  

	Print Name(s)	 		 	Social Security Number(s)
			
		 		 	
	  
	 		 	  

	Signature(s) of Purchaser(s)	 		 	Signature(s) of Purchaser(s)
			
	Address:	 		 	
			
	  
	 		 	
			
	  
	 		 	
			
	  
	 		 	
					
	Telephone:	 	  
	 		 	Fax:	 	  

					
	Email:	 	  
	 		 		 	

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

									
	Full Value Partners, L.P.	 		 	
	  
	 		 	  

	Name of Entity	 		 	Federal Taxpayer ID Number
				
	By:	 	 /s/ Andrew Dakos
	 		 	 Delaware

	Name:	 	 Andrew Dakos
	 		 	State of Organization
	Title:	 	 Manager – Bulldog Investors, LLC
	 		 		 	
			
	Address:	 		 	
			
	 Bulldog Investors, LLC
	 		 	
			
	 Park 80 West – Plaza Two
	 		 	
			
	 250 Pehle Avenue, Suite 708
	 		 	
			
	 Saddle Brook, NJ 07663
	 		 	
					
	Telephone:	 	 201-881-7101
	 		 	Fax:	 	 201-556-0097

			
	Email: adakos@bulldoginvestors.com	 		 	

 [PURCHASER SIGNATURE PAGE TO SECURITIES PURCHASE AGREEMENT] 

Aggregate Principal Amount of Convertible Notes to be Acquired: $210,000 

Aggregate Principal Amount of Non-Convertible Notes to be Acquired: $140,000 

Number of Warrant Shares to be Acquired: 14,737 

Aggregate Purchase Price (Subscription Amount): $350,000 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

									
		 		 	
	  
	 		 	  

	Print Name(s)	 		 	Social Security Number(s)
			
		 		 	
	  
	 		 	  

	Signature(s) of Purchaser(s)	 		 	Signature(s) of Purchaser(s)
			
	Address:	 		 	
			
	  
	 		 	
			
	  
	 		 	
			
	  
	 		 	
					
	Telephone:	 	  
	 		 	Fax:	 	  

					
	Email:	 	  
	 		 		 	

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

									
	Full Value Special Situations Fund, L.P.	 		 	
	  
	 		 	  

	Name of Entity	 		 	Federal Taxpayer ID Number
				
	By:	 	 /s/ Andrew Dakos
	 		 	 Delaware

	Name:	 	 Andrew Dakos
	 		 	State of Organization
	Title:	 	 Manager – Bulldog Investors, LLC
	 		 		 	
			
	Address:	 		 	
			
	 Bulldog Investors, LLC
	 		 	
			
	 Park 80 West – Plaza Two
	 		 	
			
	 250 Pehle Avenue, Suite 708
	 		 	
			
	 Saddle Brook, NJ 07663
	 		 	
					
	Telephone:	 	 201-881-7101
	 		 	Fax:	 	 201-556-0097

			
	Email: adakos@bulldoginvestors.com	 		 	

 [PURCHASER SIGNATURE PAGE TO SECURITIES PURCHASE AGREEMENT] 

Aggregate Principal Amount of Convertible Notes to be Acquired: $450,000 

Aggregate Principal Amount of Non-Convertible Notes to be Acquired: $300,000 

Number of Warrant Shares to be Acquired: 31,579 

Aggregate Purchase Price (Subscription Amount): $750,000 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

									
		 		 	
	  
	 		 	  

	Print Name(s)	 		 	Social Security Number(s)
			
		 		 	
	  
	 		 	  

	Signature(s) of Purchaser(s)	 		 	Signature(s) of Purchaser(s)
			
	Address:	 		 	
			
	  
	 		 	
			
	  
	 		 	
			
	  
	 		 	
					
	Telephone:	 	  
	 		 	Fax:	 	  

					
	Email:	 	  
	 		 		 	

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

									
	Calapasas West Partners, L.P.	 		 	
	  
	 		 	  

	Name of Entity	 		 	Federal Taxpayer ID Number
				
	By:	 	 /s/ Andrew Dakos
	 		 	 Delaware

	Name:	 	 Andrew Dakos
	 		 	State of Organization
	Title:	 	 Manager – Bulldog Investors, LLC
	 		 		 	
			
	Address:	 		 	
			
	 Bulldog Investors, LLC
	 		 	
			
	 Park 80 West – Plaza Two
	 		 	
			
	 250 Pehle Avenue, Suite 708
	 		 	
			
	 Saddle Brook, NJ 07663
	 		 	
					
	Telephone:	 	 201-881-7101
	 		 	Fax:	 	 201-556-0097

			
	Email: adakos@bulldoginvestors.com	 		 	

 [PURCHASER SIGNATURE PAGE TO SECURITIES PURCHASE AGREEMENT] 

Aggregate Principal Amount of Convertible Notes to be Acquired: $750,000 

Aggregate Principal Amount of Non-Convertible Notes to be Acquired: $500,000 

Number of Warrant Shares to be Acquired: 52,632 

Aggregate Purchase Price (Subscription Amount): $1,250,000 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

									
		 		 	
	  
	 		 	  

	Print Name(s)	 		 	Social Security Number(s)
			
		 		 	
	  
	 		 	  

	Signature(s) of Purchaser(s)	 		 	Signature(s) of Purchaser(s)
			
	Address:	 		 	
			
	  
	 		 	
			
	  
	 		 	
			
	  
	 		 	
					
	Telephone:	 	  
	 		 	Fax:	 	  

					
	Email:	 	  
	 		 		 	

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

									
	Steady Gain Partners, L.P.	 		 	
	  
	 		 	  

	Name of Entity	 		 	Federal Taxpayer ID Number
				
	By:	 	 /s/ Andrew Dakos
	 		 	 Delaware

	Name:	 	 Andrew Dakos
	 		 	State of Organization
	Title:	 	 Manager – Bulldog Investors, LLC
	 		 		 	
			
	Address:	 		 	
			
	 Bulldog Investors, LLC
	 		 	
			
	 Park 80 West – Plaza Two
	 		 	
			
	 250 Pehle Avenue, Suite 708
	 		 	
			
	 Saddle Brook, NJ 07663
	 		 	
					
	Telephone:	 	 201-881-7101
	 		 	Fax:	 	 201-556-0097

			
	Email: adakos@bulldoginvestors.comEX-10.2

 Exhibit 10.2 

REGISTRATION RIGHTS AGREEMENT 

This Registration Rights Agreement (this “Agreement”) is made and entered into as of December 16, 2013, by and among
Wheeler Real Estate Investment Trust, Inc., a Maryland corporation (the “Company”), and the several purchasers signatory hereto (each, a “Purchaser,” and collectively, the “Purchasers”). 

This Agreement is made pursuant to the Securities Purchase Agreement dated as of the date hereof between the Company and each Purchaser (the
“Purchase Agreement”). 
 NOW, THEREFORE, IN CONSIDERATION of the mutual covenants contained in this Agreement, and
for other good and valuable consideration, the receipt and adequacy of which are hereby acknowledged, the Company and each of the Purchasers agree as follows: 

1. Definitions. Capitalized terms used and not otherwise defined herein that are defined in the Purchase Agreement shall have the
meanings given such terms in the Purchase Agreement. As used in this Agreement, the following terms shall have the following meanings: 

“Advice” has the meaning set forth in Section 6(c). 

“Allowable Suspension Period” has the meaning set forth in Section 6(c). 

“Agreement” has the meaning set forth in the Preamble. 

“Business Day” means a day, other than a Saturday or Sunday, on which banking institutions in the Commonwealth of Virginia
are open for the general transaction of business. 
 “Commission” means the Securities and Exchange Commission. 

“Common Stock” means the common stock of the Company, par value $0.01 per share, and any securities into which such common
stock may hereinafter be reclassified. 
 “Company” has the meaning set forth in the Preamble. 

“Effective Date” means the date that the Registration Statement filed pursuant to Section 2(a) is first declared
effective by the Commission. 
 “Effectiveness Deadline” means, with respect to the Initial Registration Statement or the
New Registration Statement, the one hundred fiftieth (150th) calendar day following the Final Closing Date; provided, however, that if the Company is notified by the Commission that the Initial Registration Statement or the New Registration
Statement will not be reviewed or is no longer subject to further review and comments, the Effectiveness Deadline as to such Registration Statement shall be the fifth (5th) Trading Day following the date on which the Company is so notified if
such date precedes the dates otherwise required above; provided, further, that if the Effectiveness Deadline falls on a Saturday, Sunday or other day that the Commission is closed for business, the Effectiveness Deadline shall be extended to the
next Business Day on which the Commission is open for business. 
 “Effectiveness Period” has the meaning set forth in
Section 2(b). 
 “Event” has the meaning set forth in Section 2(c). 

“Event Date” has the meaning set forth in Section 2(c). 

 “Exchange Act” means the Securities Exchange Act of 1934, as amended, and the
rules and regulations promulgated thereunder. 
 “Filing Deadline” means, with respect to the Initial Registration
Statement required to be filed pursuant to Section 2(a), the sixtieth (60th) calendar day following the Final Closing Date; provided, however, that if the Filing Deadline falls on
a Saturday, Sunday or other day that the Commission is closed for business, the Filing Deadline shall be extended to the next Business Day on which the Commission is open for business. 

“FINRA” has meaning set forth in Section 3(i). 

“Holder” or “Holders” means the holder or holders, as the case may be, from time to time of Registrable
Securities. 
 “Indemnified Party” has the meaning set forth in Section 5(c). 

“Indemnifying Party” has the meaning set forth in Section 5(c). 

“Initial Registration Statement” means the initial Registration Statement filed pursuant to Section 2(a) of this
Agreement. 
 “Liquidated Damages” has the meaning set forth in Section 2(c). 

“Losses” has the meaning set forth in Section 5(a). 

“New Registration Statement” has the meaning set forth in Section 2(a). 

“Prospectus” means the prospectus included in a Registration Statement (including, without limitation, a prospectus that
includes any information previously omitted from a prospectus filed as part of an effective Registration Statement in reliance upon Rule 430A promulgated under the Securities Act), as amended or supplemented by any prospectus supplement, with
respect to the terms of the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements to such prospectus, including post effective amendments, and all material incorporated by
reference or deemed to be incorporated by reference in such prospectus. 
 “Purchase Agreement” has the meaning set forth
in the Recitals. “Purchaser” or “Purchasers” has the meaning set forth in the Preamble. 
 “Registrable
Securities” means all of the Underlying Shares (as defined in the Purchase Agreement) and any securities issued or issuable upon any stock split, dividend or other distribution, recapitalization or similar event with respect to the
foregoing; provided, that the Holder has completed and delivered to the Company a Selling Stockholder Questionnaire; and, provided further, that with respect to a particular Holder, such Holder’s Underlying Shares shall cease to be Registrable
Securities upon the earliest to occur of the following: (A) a sale pursuant to a Registration Statement or Rule 144 under the Securities Act (in which case, only such securities sold by the Holder shall cease to be a Registrable Securities); or
(B) becoming eligible for resale by the Holder under Rule 144 without the requirement for the Company to be in compliance with the current public information required under Rule 144 and without volume or manner-of-sale restrictions as
determined by Company Counsel, pursuant to a written opinion letter to such effect that is addressed and delivered to, and reasonably acceptable to, the Transfer Agent. 

“Registration Statements” means any one or more registration statements of the Company filed under the Securities Act that
covers the resale of any of the Registrable Securities pursuant to the 

 
provisions of this Agreement (including, without limitation, the Initial Registration Statement, the New Registration Statement and any Remainder Registration Statement), amendments and
supplements to such registration statements, including post-effective amendments, and all exhibits and all material incorporated by reference or deemed to be incorporated by reference in such registration statements. 

“Remainder Registration Statement” has the meaning set forth in Section 2(a). 

“Rule 144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. 

“Rule 415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. 

“Rule 424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule. 

“SEC Guidance” means (i) any publicly-available written guidance, comments, requirements or requests of the Commission
staff and (ii) the Securities Act. 
 “Securities Act” means the Securities Act of 1933, as amended, and the rules and
regulations promulgated thereunder. 
 “Selling Stockholder Questionnaire” means a questionnaire in the form attached as
Annex B hereto, or such other form of questionnaire as may reasonably be adopted by the Company from time to time. 
 2.
Registration. 
 (a) On or prior to the Filing Deadline, the Company shall prepare and file with the Commission a Registration
Statement covering the resale of all of the Registrable Securities not already covered by an existing and effective Registration Statement for an offering to be made on a continuous basis pursuant to Rule 415 or, if Rule 415 is not available for
offers and sales of the Registrable Securities, by such other means of distribution of Registrable Securities as the Company may reasonably determine (the “Initial Registration Statement”). The Initial Registration Statement shall
be on Form S-3 or such other form available to the Company to register for resale the Registrable Securities as a secondary offering, subject to the provisions of Section 2(e), and shall contain (except if otherwise required pursuant to
written comments received from the Commission upon a review of such Registration Statement) the “Plan of Distribution” section substantially in the form attached hereto as Annex A (which may be modified to respond to
comments, if any, provided by the Commission). Notwithstanding the registration obligations set forth in this Section 2, in the event the Commission informs the Company that all of the Registrable Securities cannot, as a result of the
application of Rule 415, be registered for resale as a secondary offering on a single registration statement, the Company agrees to promptly (i) inform each of the Holders thereof and use its commercially reasonable efforts to file amendments
to the Initial Registration Statement as required by the Commission and/or (ii) withdraw the Initial Registration Statement and file a new registration statement (a “New Registration Statement”), in either case covering the
maximum number of Registrable Securities permitted to be registered by the Commission, on such form available to the Company to register for resale the Registrable Securities as a secondary offering; provided, however, that prior to filing such
amendment or New Registration Statement, the Company shall be obligated to use its commercially reasonable efforts to advocate with the Commission for the 

 
registration of all of the Registrable Securities in accordance with the SEC Guidance, including without limitation, Securities Act Rules Compliance and Disclosure Interpretation 612.09.
Notwithstanding any other provision of this Agreement, if any SEC Guidance sets forth a limitation of the number of Registrable Securities or other shares of Common Stock, if any, permitted to be registered on a particular Registration Statement as
a secondary offering (and notwithstanding that the Company used diligent efforts to advocate with the Commission for the registration of all or a greater number of Registrable Securities), the number of Registrable Securities or other shares of
Common Stock to be registered on such Registration Statement will be reduced as follows: first, the Company shall reduce or eliminate the shares of Common Stock that are not Registrable Securities hereunder; and second, the Company shall reduce the
Registrable Securities to be included by all Holders on a pro rata basis based on the total number of unregistered Registrable Securities held by such Holders (with each Holder deciding, in its sole discretion, the manner in which its Registrable
Securities subject to reduction shall be reduced), subject to a determination by the Commission that certain Holders must be reduced before other Holders based on the number of Registrable Securities held by such Holders. In the event the Company
amends the Initial Registration Statement or files a New Registration Statement, as the case may be, under clauses (i) or (ii) above, the Company will use its commercially reasonable efforts to file with the Commission, as promptly as
allowed by Commission or SEC Guidance provided to the Company or to registrants of securities in general, one or more registration statements on such form available to the Company to register for resale those Registrable Securities that were not
registered for resale on the Initial Registration Statement, as amended, or the New Registration Statement (each, a “Remainder Registration Statement”). 

(b) The Company shall use its commercially reasonable efforts to cause each Registration Statement to be declared effective by the Commission
as soon as practicable and, with respect to the Initial Registration Statement or a New Registration Statement, as applicable, no later than the Effectiveness Deadline (including filing with the Commission a request for acceleration of effectiveness
in accordance with Rule 461 promulgated under the Securities Act), and shall use its commercially reasonable efforts to keep each Registration Statement continuously effective under the Securities Act until the earlier of (i) such time as all
of the Registrable Securities covered by such Registration Statement have been publicly sold by the Holders or (ii) the date that all Registrable Securities covered by such Registration Statement may be sold by non-affiliates without volume or
manner-of-sale restrictions under Rule 144, without the requirement for the Company to be in compliance with the current public information requirements under Rule 144 as determined by Company Counsel pursuant to a written opinion letter to such
effect, addressed and delivered to, and reasonably acceptable to, the Transfer Agent (the “Effectiveness Period”). The Company shall notify the Holders via fax transmission or electronic mail of the effectiveness of a Registration
Statement prior to 9:00 A.M. Eastern time on the first Trading Day after the Effective Date. The Company shall, by 9:30 A.M. Eastern time on the first Trading Day after the Effective Date, file a final Prospectus with the Commission, as required by
Rule 424(b). 
 (c) If: (i) the Initial Registration Statement is not filed with the Commission on or prior to the Filing Deadline,
(ii) the Initial Registration Statement or the New Registration Statement, as applicable, is not declared effective by the Commission (or otherwise does not become effective) for any reason on or prior to the Effectiveness Deadline,
(iii) after its Effective Date, (A) such Registration Statement ceases for any reason (including, without limitation, by reason of a stop order, or the Company’s failure to update the Registration Statement) to remain continuously
effective as to all Registrable Securities included in such Registration Statement or (B) the Holders are not permitted to utilize the Prospectus therein to resell such Registrable Securities (in each case of (A) and (B), other than during
an Allowable Suspension Period), or (iv) after the date that is six months following the Closing Date, and only in the event a Registration Statement is not effective or available to sell all Registrable Securities, the Company fails to file
with the Commission any required reports under Section 13 or 15(d) of the Exchange Act such that it is not in compliance with Rule 144(c)(1) as a result of which the Holders who are not affiliates are unable to sell Registrable Securities
without restriction under Rule 144 (any 

 
such failure or breach in clauses (i) through (iv) above being referred to as an “Event,” and the date on which such Event occurs being referred to as an “Event
Date”), then in addition to any other rights the Holders may have hereunder or under applicable law, the Company shall pay to each Holder, as partial liquidated damages and not as a penalty (“Liquidated Damages”),
(1) on each such Event Date, an amount in cash equal to one and one-half percent (1.5%) of the aggregate purchase price paid by such Holder pursuant to the Purchase Agreement for any unregistered Registrable Securities held by such Holder
on the Event Date, and (2) on each monthly anniversary of each such Event Date (if the applicable Event shall not have been cured by such date) until the applicable Event is cured, an amount in cash equal to one percent (1.0%) of the
aggregate purchase price paid by such Holder pursuant to the Purchase Agreement for any unregistered Registrable Securities held by such Holder on the Event Date. The parties agree that, notwithstanding anything to the contrary herein or in the
Purchase Agreement, no Liquidated Damages shall be payable (x) if, as of the relevant Event Date, the Registrable Securities may be sold by non-affiliates without volume or manner of sale restrictions under Rule 144 and the Company is in
compliance with the current public information requirements under Rule 144, as determined by Company Counsel pursuant to a written opinion letter to such effect, addressed and delivered to, and reasonably acceptable to the Transfer Agent, or
(y) with respect to any period after the expiration of the Effectiveness Period (it being understood that this clause shall not relieve the Company of any Liquidated Damages accruing prior to the expiration of the Effectiveness Period. If the
Company fails to pay any Liquidated Damages pursuant to this Section 2(c) in full within five Business Days after the date payable, the Company will pay interest thereon at a rate of one and one-half percent (1.5%) per month (or
such lesser maximum amount that is permitted to be paid by applicable law) to the Holder, accruing daily from the date such Liquidated Damages are due until such amounts, plus all such interest thereon, are paid in full. The Liquidated Damages
pursuant to the terms hereof shall apply on a daily pro-rata basis for any portion of a month prior to the cure of an Event, except in the case of the first Event Date. The Company shall not be liable for Liquidated Damages under this Agreement as
to any Registrable Securities which are not permitted by the Commission to be included in a Registration Statement due solely to SEC Guidance from the time that it is determined that such Registrable Securities are not permitted to be registered
until such time as the provisions of this Agreement as to a Remainder Registration Statement required to be filed hereunder are triggered, in which case the provisions of this Section 2(c) shall once again apply, if applicable. In such
case, the Liquidated Damages shall be calculated to only apply to the percentage of Registrable Securities which are permitted in accordance with SEC Guidance to be included in such Registration Statement. With respect to any Purchaser that fails to
timely provide the Company with information requested by the Company and necessary to complete the Registration Statement in accordance with the requirements of the Securities Act, the Effectiveness Deadline for a Registration Statement shall be
extended without default or Liquidated Damages hereunder in the event that the Company’s failure to obtain the effectiveness of the Registration Statement on a timely basis results from the failure of such Purchaser to timely provide the
Company with such information (for purposes of clarification, the Effectiveness Deadline would be extended only with respect to Registrable Securities held by such Purchaser and not with respect to Registrable Securities held by other Purchasers
that have not failed to timely provide the Company with such information). 
 (d) Each Holder agrees to furnish to the Company a completed
Selling Stockholder Questionnaire not more than 10 Trading Days following the date of this Agreement. At least 10 Trading Days prior to the first anticipated filing date of a Registration Statement for any registration under this Agreement, the
Company will notify each Holder of the information the Company requires from that Holder other than the information contained in the Selling Stockholder Questionnaire, if any, which shall be completed and delivered to the Company promptly upon
request and, in any event, within three Trading Days prior to the applicable anticipated filing date. Each Holder further agrees that it shall not be entitled to be named as a selling security holder in the Registration Statement or use the
Prospectus for offers and resales of Registrable Securities at any time, unless such Holder has returned to the Company a completed and signed Selling Stockholder Questionnaire and a response to any requests for further information as described in
the previous sentence. If a Holder of Registrable Securities returns a Selling 

 
Stockholder Questionnaire or a request for further information, in either case, after its respective deadline, the Company shall use its commercially reasonable efforts to take such actions as
are required to name such Holder as a selling security holder in the Registration Statement or any pre-effective or post-effective amendment thereto and to include (to the extent not theretofore included) in the Registration Statement the
Registrable Securities identified in such late Selling Stockholder Questionnaire or request for further information. Each Holder acknowledges and agrees that the information in the Selling Stockholder Questionnaire or request for further information
as described in this Section 2(d) will be used by the Company in the preparation of the Registration Statement and hereby consents to the inclusion of such information in the Registration Statement. 

3. Registration Procedures. In connection with the Company’s registration obligations hereunder: 

(a) The Company shall, not less than three Trading Days prior to the filing of each Registration Statement and not less than one Trading Day
prior to the filing of any related Prospectus or any amendment or supplement thereto (except for Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K and any similar or successor reports), (i) furnish to
the Holder copies of such Registration Statement, Prospectus or amendment or supplement thereto, as proposed to be filed, which documents will be subject to the review of such Holder (it being acknowledged and agreed that if a Holder does not object
to or comment on the aforementioned documents within such three Trading Day or one Trading Day period, as the case may be, then the Holder shall be deemed to have consented to and approved the use of such documents) and (ii) use commercially
reasonable efforts to cause its officers and directors, counsel and independent registered public accountants to respond to such inquiries as shall be necessary, in the reasonable opinion of respective counsel to each Holder, to conduct a reasonable
review. 
 (b) (i) The Company shall prepare and file with the Commission such amendments (including post-effective amendments) and
supplements, to each Registration Statement and the Prospectus used in connection therewith as may be necessary to keep such Registration Statement continuously effective as to the applicable Registrable Securities for its Effectiveness Period;
(ii) the Company shall cause the related Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and, as so supplemented or amended, to be filed pursuant to Rule 424;
(iii) the Company shall respond as promptly as reasonably practicable to any comments received from the Commission with respect to each Registration Statement or any amendment thereto and, as promptly as reasonably practicable, provide the
Holders true and complete copies of all correspondence from and to the Commission relating to such Registration Statement that pertains to the Holders as “Selling Stockholders” but not any comments that would result in the disclosure to
the Holders of material and non-public information concerning the Company; and (iv) the Company shall comply in all material respects with the provisions of the Securities Act and the Exchange Act with respect to the disposition of all
Registrable Securities covered by a Registration Statement until such time as all of such Registrable Securities shall have been disposed of (subject to the terms of this Agreement) in accordance with the intended methods of disposition by the
Holders thereof as set forth in such Registration Statement as so amended or in such Prospectus as so supplemented; provided, however, that each Purchaser shall be responsible for the delivery of the Prospectus to the Persons to whom such Purchaser
sells any of the Registrable Securities (including in accordance with Rule 172 under the Securities Act), and each Purchaser agrees to dispose of Registrable Securities in compliance with the “Plan of Distribution” described in the
Registration Statement and otherwise in compliance with applicable federal and state securities laws. In the case of amendments and supplements to a Registration Statement which are required to be filed pursuant to this Agreement (including pursuant
to this Section 3(b) by reason of the Company filing a report on Form 10-K, Form 10-Q or Form 8-K or any analogous report under the Exchange Act), the Company shall have incorporated such report by reference into such Registration
Statement, if applicable, or shall file such amendments or supplements with the Commission on the same day on which the Exchange Act report which created the requirement for the Company to amend or supplement such Registration Statement was filed.

 (c) The Company shall notify the Holders (which notice shall, pursuant to clauses through
(v) hereof, be accompanied by an instruction to suspend the use of the Prospectus until the requisite changes have been made) as promptly as reasonably practicable (and, in the case of (i)(A) below, not less than one Trading Day prior to such
filing): (i)(A) when a Prospectus or any Prospectus supplement or post-effective amendment to a Registration Statement is proposed to be filed; (B) when the Commission notifies the Company whether there will be a “review” of such
Registration Statement and whenever the Commission comments in writing on any Registration Statement (in which case the Company shall provide to each of the Holders true and complete copies of all comments that pertain to the Holders as a
“Selling Stockholder” or to the “Plan of Distribution” and all written responses thereto, but not information that the Company believes would constitute material and non-public information); and (C) with respect to each
Registration Statement or any post-effective amendment, when the same has become effective; (ii) of any request by the Commission or any other federal or state governmental authority for amendments or supplements to a Registration Statement or
Prospectus or for additional information that pertains to the Holders as “Selling Stockholders” or the “Plan of Distribution”; (iii) of the issuance by the Commission or any other federal or state governmental authority of
any stop order suspending the effectiveness of a Registration Statement covering any or all of the Registrable Securities or the initiation of any Proceedings for that purpose; of the receipt by the Company of any notification with respect to the
suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose; and (v) of the occurrence of any event or
passage of time that makes the financial statements included in a Registration Statement ineligible for inclusion therein or any statement made in such Registration Statement or Prospectus or any document incorporated or deemed to be incorporated
therein by reference untrue in any material respect or that requires any revisions to such Registration Statement, Prospectus or other documents so that, in the case of such Registration Statement or the Prospectus, as the case may be, it will not
contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus, form of prospectus or supplement thereto, in light of the
circumstances under which they were made) not misleading. 
 (d) The Company shall use commercially reasonable efforts to avoid the issuance
of, or, if issued, obtain the withdrawal of (i) any order suspending the effectiveness of a Registration Statement, or (ii) any suspension of the qualification (or exemption from qualification) of any of the Registrable Securities for sale
in any jurisdiction, as soon as practicable. 
 (e) The Company shall, if requested by a Holder, furnish to such Holder, without charge, at
least one conformed copy of each Registration Statement and each amendment thereto and all exhibits to the extent requested by such Person (including those previously furnished or incorporated by reference) promptly after the filing of such
documents with the Commission; provided, that the Company shall have no obligation to provide any document pursuant to this clause that is available on the Commission’s EDGAR system. 

(f) The Company shall, prior to any resale of Registrable Securities by a Holder, use its commercially reasonable efforts to register or
qualify or cooperate with the selling Holders in connection with the registration or qualification (or exemption from the registration or qualification) of such Registrable Securities for the resale by the Holder under the securities or blue sky
laws of such jurisdictions within the United States as any Holder reasonably requests in writing, to keep each registration or qualification (or exemption therefrom) effective during the Effectiveness Period and to do any and all other acts or
things reasonably necessary to enable the disposition in such jurisdictions of the Registrable Securities covered by each Registration Statement; provided, that the Company shall not be required to qualify generally to do business in any
jurisdiction where it is not then so qualified, or subject the Company to any material tax in any such jurisdiction where it is not then so subject. 

 (g) If requested by a Holder, the Company shall cooperate with such Holder to facilitate the
timely preparation and delivery of certificates representing Registrable Securities to be delivered to a transferee pursuant to the Registration Statement, which certificates shall be free, to the extent permitted by the Purchase Agreement and under
applicable law, of all restrictive legends, and to enable such Registrable Securities to be in such denominations and registered in such names as any such Holder may reasonably request. Notwithstanding the foregoing, certificates for Registrable
Securities free from all restrictive legends may instead be transmitted by the Transfer Agent to a Holder by crediting the account of such Holder’s prime broker with DTC as directed by such Holder. 

(h) The Company shall, following the occurrence of any event contemplated by Section 3(c), as promptly as reasonably practicable
(taking into account the Company’s good faith assessment of any adverse consequences to the Company and its stockholders of the premature disclosure of such event), prepare and file a supplement or amendment, including a post-effective
amendment, to the affected Registration Statement or a supplement to the related Prospectus or any document incorporated or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, no
Registration Statement nor any Prospectus will contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein (in the case of any Prospectus, form of
prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading. 
 (i) The Company may require
each selling Holder to furnish to the Company a certified statement as to (i) the number of shares of Common Stock beneficially owned by such Holder and any Affiliate thereof, (ii) any Financial Industry Regulatory Authority
(“FINRA”) affiliations, (iii) any natural persons who have the power to vote or dispose of any shares of Common Stock beneficially owned by such Holder and any Affiliate thereof, and (iv) any other information as may be
requested by the Commission, FINRA or any state securities commission. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of Registrable Securities because any Holder fails to furnish
such information within three (3) Trading Days of the Company’s request, any Liquidated Damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise occur solely because of such delay shall
be suspended as to such Holder only, until such information is delivered to the Company. 
 (j) The Company shall cooperate with any
registered broker-dealer through which a Holder proposes to make sales of its Registrable Securities in effecting such broker-dealer’s filing with FINRA pursuant to FINRA Rule 5110, as reasonably requested by any such Holder, and the Company
shall pay the filing fee required for the first such filing within two (2) Business Days of the request therefor (so long as the broker-dealer is receiving no more than a customary brokerage commission in connection with such sales). 

(k) The Company agrees to deliver promptly to each Holder, without charge, as many copies of each Prospectus (including each form of
prospectus) and each amendment or supplement thereto as such Holder may reasonably request. 
 (l) The Company shall make available to its
security holders, as soon as reasonably practicable, but not later than the Availability Date (as defined below), an earnings statement covering a period of at least twelve (12) months, beginning after the effective date of each Registration
Statement, which earnings statement shall satisfy the provisions of Section 11(a) of the Securities Act, including Rule 158 promulgated thereunder (for the purpose of this Section 3(m), “Availability Date” means the
45th day following the end of the fourth fiscal quarter that includes the effective date of such Registration Statement, except that, if such fourth fiscal quarter is the last quarter of the Company’s fiscal year, “Availability
Date” means the 90th day after the end of such fourth fiscal quarter). 

 4. Registration Expenses. All fees and expenses incident to the Company’s performance
of or compliance with its obligations under this Agreement (excluding any underwriting discounts and selling commissions and all legal fees and expenses of legal counsel for any Holder) shall be borne by the Company whether or not any Registrable
Securities are sold pursuant to a Registration Statement. The fees and expenses referred to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation, fees and expenses
(A) with respect to filings required to be made with any Trading Market on which the Common Stock is then listed or quoted for trading, and (B) with respect to compliance with applicable state securities or blue sky laws (including,
without limitation, fees and disbursements of Company Counsel in connection with blue sky qualifications or exemptions of the Registrable Securities), (ii) printing expenses (including, without limitation, expenses of printing certificates for
Registrable Securities), (iii) messenger, telephone and delivery expenses, (iv) fees and disbursements of Company Counsel, (v) Securities Act liability insurance, if the Company so desires such insurance, and (vi) fees and
expenses of all other Persons retained by the Company in connection with the consummation of the transactions contemplated by this Agreement. In addition, the Company shall be responsible for all of its internal expenses incurred in connection with
the consummation of the transactions contemplated by this Agreement (including, without limitation, all salaries and expenses of its officers and employees performing legal or accounting duties) and the expense of any annual audit. In no event shall
the Company be responsible for any underwriting, broker or similar fees or commissions of any Holder or, except to the extent provided for in the Transaction Documents, any legal fees or other costs of the Holders. 

5. Indemnification. 
 (a)
Indemnification by the Company. The Company shall indemnify, defend and hold harmless each Holder, its officers, directors, agents, partners, members, managers, investment advisers, stockholders, Affiliates and employees, each Person who
controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act) and the officers, directors, partners, members, managers, stockholders, agents and employees of each such controlling
Person, to the fullest extent permitted by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, reasonable costs of preparation and investigation and reasonable attorneys’
fees) and expenses (collectively, “Losses”), as incurred, that arise out of or are based upon (i) any untrue or alleged untrue statement of a material fact contained in any Registration Statement, any Prospectus or any form of
prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising out of or relating to any omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements
therein (in the case of any Prospectus or form of prospectus or supplement thereto, in light of the circumstances under which they were made) not misleading, or (ii) any violation or alleged violation by the Company of the Securities Act,
Exchange Act or any state securities law or any rule or regulation thereunder, in connection with the performance of its obligations under this Agreement, except to the extent, but only to the extent, that (A) such untrue statements, alleged
untrue statements, omissions or alleged omissions are based solely upon information regarding such Holder furnished in writing to the Company by such Holder expressly for use therein, or to the extent that such information relates to such Holder or
such Holder’s proposed method of distribution of Registrable Securities and was reviewed and approved in writing by such Holder expressly for use in the Registration Statement, such Prospectus or such form of prospectus or in any amendment or
supplement thereto (it being understood that each Holder has approved Annex A hereto for this purpose) or (B) in the case of an occurrence of an event of the type specified in Section 3(c)(iii)-(v), the Holder uses an
outdated or defective Prospectus after the Company has notified such Holder in writing that the Prospectus is outdated or defective and prior to the receipt by such Holder of the Advice contemplated in Section 6(c) below or (C) any
such Losses arise out of the Holder’s (or any other indemnified Person’s) 

 
failure to send or give a copy of the Prospectus or supplement (as then amended or supplemented), if required, pursuant to Rule 172 under the Securities Act (or any successor rule) to the Persons
asserting an untrue statement or alleged untrue statement or omission or alleged omission at or prior to the written confirmation of the sale of Registrable Securities to such Person if such statement or omission was corrected in such Prospectus or
supplement. The Company shall notify the Holders promptly of the institution of any Proceeding arising from or in connection with the transactions contemplated by this Agreement of which the Company is aware. Such indemnity shall remain in full
force and effect regardless of any investigation made by or on behalf of an Indemnified Party (as defined in Section 5(b)) and shall survive the transfer of the Registrable Securities by the Holders. 

(b) Conduct of Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled to indemnity
hereunder (an “Indemnified Party”), such Indemnified Party shall promptly notify the Person from whom indemnity is sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall have the right to
participate in the defense thereof. Legal counsel for such defense shall be selected by the Indemnified Party and be reasonably satisfactory to the Indemnifying Party. The Indemnifying Party shall be responsible for payment of all reasonable fees
and expenses incurred in connection with defense thereof. The failure of any Indemnified Party to give timely notice shall not relieve the Indemnifying Party of its obligations or liabilities under this Section 5, except (and only) to
the extent that such failure shall have materially and adversely prejudiced the Indemnifying Party. Subject to the terms of this Agreement, all fees and expenses of the Indemnified Party (including reasonable fees and expenses to the extent incurred
in connection with investigating or preparing to defend such Proceeding in a manner not inconsistent with this Section 5) shall be paid to the Indemnified Party, as incurred, within 20 Trading Days of written notice thereof to the
Indemnifying Party; provided, that the Indemnified Party shall promptly reimburse the Indemnifying Party for that portion of such fees and expenses applicable to such actions for which such Indemnified Party is finally judicially determined to not
be entitled to indemnification hereunder). 
 (c) Contribution. If a claim for indemnification under Section 5(a) is
unavailable to an Indemnified Party or insufficient to hold an Indemnified Party harmless for any Losses, then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid or payable by such
Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative fault of the Indemnifying Party and Indemnified Party in connection with the actions, statements or omissions that resulted in such Losses as
well as any other relevant equitable considerations. The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether any action in question, including any untrue or alleged untrue
statement of a material fact or omission or alleged omission of a material fact, has been taken or made by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties’ relative intent, knowledge, access
to information and opportunity to correct or prevent such action, statement or omission. The amount paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in this Agreement, any
reasonable attorneys’ or other reasonable fees or expenses incurred by such party in connection with any Proceeding to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this
Section 5 was available to such party in accordance with its terms. 
 The parties hereto agree that it would not be just and
equitable if contribution pursuant to this Section 5(c) were determined by pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred to in the immediately preceding
paragraph. Notwithstanding the provisions of this Section 5(c), no contribution will be made under circumstances where the maker of such contribution would not have been required to indemnify the Indemnified Party under the fault
standards set forth in this Section 5. No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such
fraudulent misrepresentation. 

 The indemnity and contribution agreements contained in this Section 5 are in addition
to any liability that the Indemnifying Parties may have to the Indemnified Parties and are not in diminution or limitation of the indemnification provisions under the Purchase Agreement. 

6. Miscellaneous. 
 (a)
Remedies. In the event of a breach by the Company or by a Holder of any of their obligations under this Agreement, each Holder or the Company, as the case may be, in addition to being entitled to exercise all rights granted by law and under
this Agreement, including recovery of damages, will be entitled to specific performance of its rights under this Agreement. The Company and each Holder agree that monetary damages would not provide adequate compensation for any losses incurred by
reason of a breach by it of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance in respect of such breach, it shall waive the defense that a remedy at law would be adequate.

 (b) Compliance. Each Holder covenants and agrees that it will comply with the prospectus delivery requirements of the Securities
Act as applicable to it (unless an exemption therefrom is available) in connection with sales of Registrable Securities pursuant to the Registration Statement and shall sell the Registrable Securities only in accordance with a method of distribution
described in the Registration Statement. 
 (c) Discontinued Disposition. By its acquisition of Registrable Securities, each Holder
agrees that, upon receipt of a notice from the Company of the occurrence of any event of the kind described in Section 3(c)(iii)-(v), such Holder will forthwith discontinue disposition of such Registrable Securities under a Registration
Statement until it is advised in writing (the “Advice”) by the Company that the use of the applicable Prospectus (as it may have been supplemented or amended) may be resumed. The Company will use its commercially reasonable efforts
to ensure that the use of the Prospectus may be resumed as promptly as is practicable. Notwithstanding any provision herein to the contrary, the Company shall be entitled to exercise its right under this Section 6(c) to suspend the
availability of a Registration Statement and Prospectus for a period not to exceed 20 consecutive calendar days or 45 calendar days (which need not be consecutive days) in any 12 month period (each suspension period complying with this provision, an
“Allowable Suspension Period”). 
 (d) Amendments and Waivers. The provisions of this Agreement, including the
provisions of this sentence, may not be amended, modified or supplemented, or waived unless the same shall be in writing and signed by the Company and Holders holding no less than 66.66% of the then outstanding Registrable Securities; provided, that
any party may give a waiver as to itself; and, provided further, that the provisions of this Agreement may be amended and the observance of any provisions hereunder may be waived without the consent of a Holder only in a manner which applies to all
Holder in the same fashion. Notwithstanding the foregoing, a waiver or consent to depart from the provisions hereof with respect to a matter that relates exclusively to the rights of certain Holders and that does not directly or indirectly affect
the rights of other Holders may be given by Holders of all of the Registrable Securities to which such waiver or consent relates; provided, however, that the provisions of this sentence may not be amended, modified, or supplemented except in
accordance with the provisions of the immediately preceding sentence. 
 (e) Notices. Any and all notices or other communications or
deliveries required or permitted to be provided hereunder shall be delivered as set forth in the Purchase Agreement. 
 (f) Successors
and Assigns. This Agreement shall inure to the benefit of and be binding upon the successors and permitted assigns of each of the parties and shall inure to the benefit of each Holder. Nothing in this Agreement, express or implied, is intended
to confer upon any party other 

 
than the parties hereto or their respective successors and assigns any rights, remedies, obligations, or liabilities under or by reason of this Agreement, except as expressly provided in this
Agreement. The Company may not assign its rights or obligations hereunder without the prior written consent of Holders holding no less than 66.66% of the then outstanding Registrable Securities, which consent will not be unreasonably withheld. Each
Holder may assign its respective rights hereunder with respect to its Registrable Securities in the manner and to the Persons as permitted under the Purchase Agreement; provided, in each case that (i) the Holder agrees in writing with the
transferee or assignee to assign such rights and related obligations under this Agreement, and for the transferee or assignee to assume such obligations, and a copy of such agreement is furnished to the Company within a reasonable time after such
assignment, (ii) the Company is, within a reasonable time after such transfer or assignment, furnished with written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights
are being transferred or assigned, (iii) at or before the time the Company received the written notice contemplated by clause (ii) of this sentence, the transferee or assignee agrees in writing with the Company to be bound by all of the
provisions contained herein and (iv) the transferee is an “accredited investor,” as that term is defined in Rule 501 of Regulation D. 

(g) Execution and Counterparts. This Agreement may be executed in two or more counterparts, each of which when so executed shall be
deemed to be an original and, all of which taken together shall constitute one and the same Agreement and shall become effective when counterparts have been signed by each party and delivered to the other party, it being understood that both parties
need not sign the same counterpart. In the event that any signature is delivered by facsimile transmission or by e-mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party
executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile or “.pdf” signature were the original thereof. 

(h) Governing Law. All questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be
determined in accordance with the provisions of the Purchase Agreement. 
 (i) Cumulative Remedies. The remedies provided herein are
cumulative and not exclusive of any other remedies provided by law. 
 (j) Additional Closings. Each Purchaser acknowledges that, in
addition to the Closing, the Company may hold one or more other closings for the purchase and sale of Units in the Offering, whether before and/or after the Closing Date; provided, that the Final Closing Date must be on or prior to the Offering
Termination Date. In the event the Company has held or will hold one or more such additional closings, the shares of Common Stock issued or issuable to purchasers in connection with such closing(s), and the shares of Common Stock issuable upon
exercise of warrants issued or issuable to purchasers in connection with such closing(s), shall be considered “Registrable Securities” for purposes of Section 2 of this Agreement. 

(k) Severability. If any term, provision, covenant or restriction of this Agreement is held by a court of competent jurisdiction to be
invalid, illegal, void or unenforceable, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect and shall in no way be affected, impaired or invalidated, and the parties hereto shall
use their good faith reasonable efforts to find and employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision, covenant or restriction. It is hereby stipulated and declared to be
the intention of the parties that they would have executed the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid, illegal, void or unenforceable. 

 (l) Headings. The headings in this Agreement are for convenience only and shall not limit
or otherwise affect the meaning hereof. 
 (m) Independent Nature of Purchasers’ Obligations and Rights. The obligations of each
Purchaser under this Agreement are several and not joint with the obligations of any other Purchaser hereunder, and no Purchaser shall be responsible in any way for the performance of the obligations of any other Purchaser hereunder. The decision of
each Purchaser to purchase the Securities pursuant to the Transaction Documents has been made independently of any other Purchaser. Nothing contained herein or in any other agreement or document delivered at any closing, and no action taken by any
Purchaser pursuant hereto or thereto, shall be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create a presumption that the Purchasers are in any way acting in concert with
respect to such obligations or the transactions contemplated by this Agreement. Each Purchaser acknowledges that no other Purchaser has acted as agent for such Purchaser in connection with making its investment hereunder and that no Purchaser will
be acting as agent of such Purchaser in connection with monitoring its investment in the Securities or enforcing its rights under the Transaction Documents. Each Purchaser shall be entitled to protect and enforce its rights, including, without
limitation, the rights arising out of this Agreement, and it shall not be necessary for any other Purchaser to be joined as an additional party in any Proceeding for such purpose. The Company acknowledges that each of the Purchasers has been
provided with the same Registration Rights Agreement for the purpose of closing a transaction with multiple Purchasers and not because it was required or requested to do so by any Purchaser. 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

 IN WITNESS WHEREOF, the parties hereto have caused this Registration Rights Agreement to be duly
executed as of the date first indicated above. 
  

			
	WHEELER REAL ESTATE INVESTMENT TRUST, INC.
		
	By:	 	 /s/ Jon S. Wheeler

		 	Jon S. Wheeler
		 	Chairman and Chief Executive Officer

 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK] 

 [PURCHASER SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT] 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

					
	  
	 		 	  

	Print Name	 		 	Print Name
			
	  
	 		 	  

	Signature of Purchaser	 		 	Signature of Purchaser

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

	
	 Special Opportunities Fund, Inc.

	Name of Entity

  

			
	By:	 	 /s/ Andrew Dakos

	Name:	 	 Andrew Dakos

	Title:	 	 Manager, Bulldog Investors, LLC

 [PURCHASER SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT] 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

					
	  
	 		 	  

	Print Name	 		 	Print Name
			
	  
	 		 	  

	Signature of Purchaser	 		 	Signature of Purchaser

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

	
	 Steady Gain Partners, L.P.

	Name of Entity

  

			
	By:	 	 /s/ Andrew Dakos

	Name:	 	 Andrew Dakos

	Title:	 	 Manager, Bulldog Investors, LLC

 [PURCHASER SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT] 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

					
	  
	 		 	  

	Print Name	 		 	Print Name
			
	  
	 		 	  

	Signature of Purchaser	 		 	Signature of Purchaser

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

	
	 Mercury Partners, L.P.

	Name of Entity

  

			
	By:	 	 /s/ Andrew Dakos

	Name:	 	 Andrew Dakos

	Title:	 	 Manager, Bulldog Investors, LLC

 [PURCHASER SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT] 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

					
	  
	 		 	  

	Print Name	 		 	Print Name
			
	  
	 		 	  

	Signature of Purchaser	 		 	Signature of Purchaser

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

	
	 Calapasas West Partners, L.P.

	Name of Entity

  

			
	By:	 	 /s/ Andrew Dakos

	Name:	 	 Andrew Dakos

	Title:	 	 Manager, Bulldog Investors, LLC

 [PURCHASER SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT] 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

					
	  
	 		 	  

	Print Name	 		 	Print Name
			
	  
	 		 	  

	Signature of Purchaser	 		 	Signature of Purchaser

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

	
	 MCM Opportunity Partners, L.P.

	Name of Entity

  

			
	By:	 	 /s/ Andrew Dakos

	Name:	 	 Andrew Dakos

	Title:	 	 Manager, Bulldog Investors, LLC

 [PURCHASER SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT] 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

					
	  
	 		 	  

	Print Name	 		 	Print Name
			
	  
	 		 	  

	Signature of Purchaser	 		 	Signature of Purchaser

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

	
	 Full Value Special Situations Fund, L.P.

	Name of Entity

  

			
	By:	 	 /s/ Andrew Dakos

	Name:	 	 Andrew Dakos

	Title:	 	 Manager, Bulldog Investors, LLC

 [PURCHASER SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT] 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

					
	  
	 		 	  

	Print Name	 		 	Print Name
			
	  
	 		 	  

	Signature of Purchaser	 		 	Signature of Purchaser

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

	
	 Opportunity Partners, L.P.

	Name of Entity

  

			
	By:	 	 /s/ Andrew Dakos

	Name:	 	 Andrew Dakos

	Title:	 	 Manager, Bulldog Investors, LLC

 [PURCHASER SIGNATURE PAGE TO REGISTRATION RIGHTS AGREEMENT] 

If Purchaser is an INDIVIDUAL, or if purchased as JOINT TENANTS, as TENANTS IN COMMON or as COMMUNITY PROPERTY: 

 

					
	  
	 		 	  

	Print Name	 		 	Print Name
			
	  
	 		 	  

	Signature of Purchaser	 		 	Signature of Purchaser

 If Purchaser is a CORPORATION, LIMITED LIABILITY COMPANY, PARTNERSHIP or TRUST: 

 

	
	 Full Value Partners, L.P.

	Name of Entity

  

			
	By:	 	 /s/ Andrew Dakos

	Name:	 	 Andrew Dakos

	Title:	 	 Manager, Bulldog Investors, LLC

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00224-of-00352.parquet"}]]